This document is an excerpt from the EUR-Lex website
Document 02009R1223-20210526
Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (recast) (Text with EEA relevance)Text with EEA relevance
Consolidated text: Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (recast) (Text with EEA relevance)Text with EEA relevance
Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (recast) (Text with EEA relevance)Text with EEA relevance
02009R1223 — EN — 26.05.2021 — 026.001
This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document
|
REGULATION (EC) No 1223/2009 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 30 November 2009 on cosmetic products (recast) (OJ L 342 22.12.2009, p. 59) |
Amended by:
|
|
|
Official Journal |
||
|
No |
page |
date |
||
|
L 114 |
1 |
25.4.2013 |
||
|
L 139 |
8 |
25.5.2013 |
||
|
L 190 |
38 |
11.7.2013 |
||
|
L 315 |
34 |
26.11.2013 |
||
|
L 107 |
5 |
10.4.2014 |
||
|
L 238 |
3 |
9.8.2014 |
||
|
COMMISSION REGULATION (EU) No 1003/2014 of 18 September 2014 |
L 282 |
1 |
26.9.2014 |
|
|
COMMISSION REGULATION (EU) No 1004/2014 of 18 September 2014 |
L 282 |
5 |
26.9.2014 |
|
|
L 193 |
115 |
21.7.2015 |
||
|
L 199 |
22 |
29.7.2015 |
||
|
L 60 |
59 |
5.3.2016 |
||
|
L 106 |
4 |
22.4.2016 |
||
|
L 106 |
7 |
22.4.2016 |
||
|
L 187 |
1 |
12.7.2016 |
||
|
L 187 |
4 |
12.7.2016 |
||
|
L 189 |
40 |
14.7.2016 |
||
|
L 198 |
10 |
23.7.2016 |
||
|
L 36 |
12 |
11.2.2017 |
||
|
L 36 |
37 |
11.2.2017 |
||
|
REGULATION (EU) 2017/745 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 5 April 2017 |
L 117 |
1 |
5.5.2017 |
|
|
Amended by: REGULATION (EU) 2020/561 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 23 April 2020 |
L 130 |
18 |
24.4.2020 |
|
|
L 174 |
16 |
7.7.2017 |
||
|
L 202 |
1 |
3.8.2017 |
||
|
L 203 |
1 |
4.8.2017 |
||
|
L 319 |
2 |
5.12.2017 |
||
|
L 158 |
1 |
21.6.2018 |
||
|
L 176 |
3 |
12.7.2018 |
||
|
L 300 |
1 |
27.11.2018 |
||
|
L 115 |
3 |
2.5.2019 |
||
|
L 115 |
5 |
2.5.2019 |
||
|
L 119 |
66 |
7.5.2019 |
||
|
L 137 |
29 |
23.5.2019 |
||
|
L 196 |
5 |
24.7.2019 |
||
|
L 286 |
3 |
7.11.2019 |
||
|
L 286 |
7 |
7.11.2019 |
||
|
L 307 |
15 |
28.11.2019 |
||
|
L 379 |
31 |
13.11.2020 |
||
|
L 379 |
34 |
13.11.2020 |
||
|
L 379 |
42 |
13.11.2020 |
||
Corrected by:
REGULATION (EC) No 1223/2009 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
of 30 November 2009
on cosmetic products
(recast)
(Text with EEA relevance)
CHAPTER I
SCOPE, DEFINITIONS
Article 1
Scope and objective
This Regulation establishes rules to be complied with by any cosmetic product made available on the market, in order to ensure the functioning of the internal market and a high level of protection of human health.
Article 2
Definitions
For the purposes of this Regulation, the following definitions shall apply:
‘cosmetic product’ means any substance or mixture intended to be placed in contact with the external parts of the human body (epidermis, hair system, nails, lips and external genital organs) or with the teeth and the mucous membranes of the oral cavity with a view exclusively or mainly to cleaning them, perfuming them, changing their appearance, protecting them, keeping them in good condition or correcting body odours;
‘substance’ means a chemical element and its compounds in the natural state or obtained by any manufacturing process, including any additive necessary to preserve its stability and any impurity deriving from the process used but excluding any solvent which may be separated without affecting the stability of the substance or changing its composition;
‘mixture’ means a mixture or solution composed of two or more substances;
‘manufacturer’ means any natural or legal person who manufactures a cosmetic product or has such a product designed or manufactured, and markets that cosmetic product under his name or trademark;
‘distributor’ means any natural or legal person in the supply chain, other than the manufacturer or the importer, who makes a cosmetic product available on the Community market;
‘end user’ means either a consumer or professional using the cosmetic product;
‘making available on the market’ means any supply of a cosmetic product for distribution, consumption or use on the Community market in the course of a commercial activity, whether in return for payment or free of charge;
‘placing on the market’ means the first making available of a cosmetic product on the Community market;
‘importer’ means any natural or legal person established within the Community, who places a cosmetic product from a third country on the Community market;
‘harmonised standard’ means a standard adopted by one of the European standardisation bodies listed in Annex I to Directive 98/34/EC of the European Parliament and of the Council of 22 June 1998 laying down a procedure for the provision of information in the field of technical standards and regulations and of rules on information society services ( 1 ) on the basis of a request made by the Commission in accordance with Article 6 of that Directive;
‘nanomaterial’ means an insoluble or biopersistant and intentionally manufactured material with one or more external dimensions, or an internal structure, on the scale from 1 to 100 nm;
‘preservatives’ means substances which are exclusively or mainly intended to inhibit the development of micro-organisms in the cosmetic product;
‘colorants’ means substances which are exclusively or mainly intended to colour the cosmetic product, the body as a whole or certain parts thereof, by absorption or reflection of visible light; in addition, precursors of oxidative hair colorants shall be deemed colorants;
‘UV-filters’ means substances which are exclusively or mainly intended to protect the skin against certain UV radiation by absorbing, reflecting or scattering UV radiation;
‘undesirable effect’ means an adverse reaction for human health attributable to the normal or reasonably foreseeable use of a cosmetic product;
‘serious undesirable effect’ means an undesirable effect which results in temporary or permanent functional incapacity, disability, hospitalisation, congenital anomalies or an immediate vital risk or death;
‘withdrawal’ means any measure aimed at preventing the making available on the market of a cosmetic product in the supply chain;
‘recall’ means any measure aimed at achieving the return of a cosmetic product that has already been made available to the end user;
‘frame formulation’ means a formulation which lists the category or function of ingredients and their maximum concentration in the cosmetic product or gives relevant quantitative and qualitative information whenever a cosmetic product is not covered or only partially covered by such a formulation. The Commission shall provide indications for the establishment of the frame formulation and adapt them regularly to technical and scientific progress.
CHAPTER II
SAFETY, RESPONSIBILITY, FREE MOVEMENT
Article 3
Safety
A cosmetic product made available on the market shall be safe for human health when used under normal or reasonably foreseeable conditions of use, taking account, in particular, of the following:
presentation including conformity with Directive 87/357/EEC;
labelling;
instructions for use and disposal;
any other indication or information provided by the responsible person defined in Article 4.
The provision of warnings shall not exempt persons defined in Articles 2 and 4 from compliance with the other requirements laid down in this Regulation.
Article 4
Responsible person
For a cosmetic product manufactured within the Community, and not subsequently exported and imported back into the Community, the manufacturer established within the Community shall be the responsible person.
The manufacturer may designate, by written mandate, a person established within the Community as the responsible person who shall accept in writing.
For an imported cosmetic product, each importer shall be the responsible person for the specific cosmetic product he places on the market.
The importer may, by written mandate, designate a person established within the Community as the responsible person who shall accept in writing.
The distributor shall be the responsible person where he places a cosmetic product on the market under his name or trademark or modifies a product already placed on the market in such a way that compliance with the applicable requirements may be affected.
The translation of information relating to a cosmetic product already placed on the market shall not be considered as a modification of that product of such a nature that compliance with the applicable requirements of this Regulation may be affected.
Article 5
Obligations of responsible persons
Responsible persons who consider or have reason to believe that a cosmetic product which they have placed on the market is not in conformity with this Regulation shall immediately take the corrective measures necessary to bring that product into conformity, withdraw it or recall it, as appropriate.
Furthermore, where the cosmetic product presents a risk to human health, responsible persons shall immediately inform the competent national authorities of the Member States in which they made the product available and of the Member State in which the product information file is readily accessible, giving details, in particular, of the non-compliance and of the corrective measures taken.
Article 6
Obligations of distributors
Before making a cosmetic product available on the market distributors shall verify that:
Where distributors consider or have reason to believe that:
Furthermore, where the cosmetic product presents a risk to human health, distributors shall immediately inform the responsible person and the competent national authorities of the Member States in which they made the product available, giving details, in particular, of the non-compliance and of the corrective measures taken.
Article 7
Identification within the supply chain
At the request of a competent authority:
This obligation shall apply for a period of three years following the date on which the batch of the cosmetic product was made available to the distributor.
Article 8
Good manufacturing practice
Article 9
Free movement
Member States shall not, for reasons related to the requirements laid down in this Regulation, refuse, prohibit or restrict the making available on the market of cosmetic products which comply with the requirements of this Regulation.
CHAPTER III
SAFETY ASSESSMENT, PRODUCT INFORMATION FILE, NOTIFICATION
Article 10
Safety assessment
In order to demonstrate that a cosmetic product complies with Article 3, the responsible person shall, prior to placing a cosmetic product on the market, ensure that the cosmetic product has undergone a safety assessment on the basis of the relevant information and that a cosmetic product safety report is set up in accordance with Annex I.
The responsible person shall ensure that:
the intended use of the cosmetic product and the anticipated systemic exposure to individual ingredients in a final formulation are taken into account in the safety assessment;
an appropriate weight-of-evidence approach is used in the safety assessment for reviewing data from all existing sources;
the cosmetic product safety report is kept up to date in view of additional relevant information generated subsequent to placing the product on the market.
The first subparagraph shall also apply to cosmetic products that have been notified under Directive 76/768/EEC.
The Commission, in close cooperation with all stakeholders, shall adopt appropriate guidelines to enable undertakings, in particular small and medium-sized enterprises, to comply with the requirements laid down in Annex I. Those guidelines shall be adopted in accordance with the regulatory procedure referred to in Article 32(2).
Article 11
Product information file
The product information file shall contain the following information and data which shall be updated as necessary:
a description of the cosmetic product which enables the product information file to be clearly attributed to the cosmetic product;
the cosmetic product safety report referred to in Article 10(1);
a description of the method of manufacturing and a statement on compliance with good manufacturing practice referred to in Article 8;
where justified by the nature or the effect of the cosmetic product, proof of the effect claimed for the cosmetic product;
data on any animal testing performed by the manufacturer, his agents or suppliers, relating to the development or safety assessment of the cosmetic product or its ingredients, including any animal testing performed to meet the legislative or regulatory requirements of third countries.
The responsible person shall make the product information file readily accessible in electronic or other format at his address indicated on the label to the competent authority of the Member State in which the file is kept.
The information contained in the product information file shall be available in a language which can be easily understood by the competent authorities of the Member State.
Article 12
Sampling and analysis
Article 13
Notification
Prior to placing the cosmetic product on the market the responsible person shall submit, by electronic means, the following information to the Commission:
the category of cosmetic product and its name or names, enabling its specific identification;
the name and address of the responsible person where the product information file is made readily accessible;
the country of origin in the case of import;
the Member State in which the cosmetic product is to be placed on the market;
the contact details of a physical person to contact in the case of necessity;
the presence of substances in the form of nanomaterials and:
their identification including the chemical name (IUPAC) and other descriptors as specified in point 2 of the Preamble to Annexes II to VI to this Regulation;
the reasonably foreseeable exposure conditions;
the name and the Chemicals Abstracts Service (CAS) or EC number of substances classified as carcinogenic, mutagenic or toxic for reproduction (CMR), of category 1A or 1B, under Part 3 of Annex VI to Regulation (EC) No 1272/2008;
the frame formulation allowing for prompt and appropriate medical treatment in the event of difficulties.
The first subparagraph shall also apply to cosmetic products notified under Directive 76/768/EEC.
As from 11 July 2013, a distributor who makes available in a Member State a cosmetic product already placed on the market in another Member State and translates, on his own initiative, any element of the labelling of that product in order to comply with national law, shall submit, by electronic means, the following information to the Commission:
the category of cosmetic product, its name in the Member State of dispatch and its name in the Member State in which it is made available, enabling its specific identification;
the Member State in which the cosmetic product is made available;
his name and address;
the name and address of the responsible person where the product information file is made readily accessible.
Where a cosmetic product has been placed on the market before 11 July 2013 but is no longer placed on the market as from that date, and a distributor introduces that product in a Member State after that date, that distributor shall communicate the following to the responsible person:
the category of cosmetic product, its name in the Member State of dispatch and its name in the Member State in which it is made available, enabling its specific identification;
the Member State in which the cosmetic product is made available;
his name and address.
On the basis of that communication, the responsible person shall submit to the Commission, by electronic means, the information referred to in paragraph 1 of this Article, where notifications according to Article 7(3) and Article 7a (4) of Directive 76/768/EEC have not been carried out in the Member State in which the cosmetic product is made available.
The Commission shall, without delay, make the information referred to in points (a) to (g) of paragraph 1, and in paragraphs 2 and 3 available electronically to all competent authorities.
That information may be used by competent authorities only for the purposes of market surveillance, market analysis, evaluation and consumer information in the context of Articles 25, 26 and 27.
The Commission shall, without delay, make the information referred to in paragraphs 1, 2 and 3 available electronically to poison centres or similar bodies, where such centres or bodies have been established by Member States.
That information may be used by those bodies only for the purposes of medical treatment.
The Commission may, taking into account technical and scientific progress and specific needs related to market surveillance, amend paragraphs 1 to 7 by adding requirements.
Those measures, designed to amend non-essential elements of this Regulation, shall be adopted in accordance with the regulatory procedure with scrutiny referred to in Article 32(3).
CHAPTER IV
RESTRICTIONS FOR CERTAIN SUBSTANCES
Article 14
Restrictions for substances listed in the Annexes
Without prejudice to Article 3, cosmetic products shall not contain any of the following:
prohibited substances
restricted substances
colorants
colorants other than those listed in Annex IV and colorants which are listed there but not used in accordance with the conditions laid down in that Annex, except for hair colouring products referred to in paragraph 2;
without prejudice to points (b), (d)(i) and (e)(i), substances which are listed in Annex IV but which are not intended to be used as colorants, and which are not used in accordance with the conditions laid down in that Annex;
preservatives
preservatives other than those listed in Annex V and preservatives which are listed there but not used in accordance with the conditions laid down in that Annex;
without prejudice to points (b), (c)(i) and (e)(i), substances listed in Annex V but which are not intended to be used as preservatives, and which are not used in accordance with the conditions laid down in that Annex;
UV-filters
UV-filters other than those listed in Annex VI and UV-filters which are listed there but not used in accordance with the conditions laid down in that Annex;
without prejudice to points (b), (c)(i) and (d)(i), substances listed in Annex VI but which are not intended to be used as UV-filters and which are not used in accordance with the conditions laid down in that Annex.
Subject to a decision of the Commission to extend the scope of Annex IV to hair colouring products, such products shall not contain colorants intended to colour the hair, other than those listed in Annex IV and colorants intended to colour the hair which are listed there but not used in accordance with the conditions laid down in that Annex.
The decision of the Commission referred to in the first subparagraph, designed to amend non-essential elements of this Regulation, shall be adopted in accordance with the regulatory procedure with scrutiny referred to in Article 32(3).
Article 15
Substances classified as CMR substances
The use in cosmetic products of substances classified as CMR substances, of category 1A or 1B under Part 3 of Annex VI to Regulation (EC) No 1272/2008 shall be prohibited.
However, such substances may be used in cosmetic products by way of exception where, subsequent to their classification as CMR substances of category 1A or 1B under Part 3 of Annex VI to Regulation (EC) No 1272/2008, all of the following conditions are fulfilled:
they comply with the food safety requirements as defined in Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety ( 2 );
there are no suitable alternative substances available, as documented in an analysis of alternatives;
the application is made for a particular use of the product category with a known exposure; and
they have been evaluated and found safe by the SCCS for use in cosmetic products, in particular in view of exposure to these products and taking into consideration the overall exposure from other sources, taking particular account of vulnerable population groups.
Specific labelling in order to avoid misuse of the cosmetic product shall be provided in accordance with Article 3 of this Regulation, taking into account possible risks linked to the presence of hazardous substances and the routes of exposure.
In order to implement this paragraph, the Commission shall amend the Annexes to this Regulation in accordance with the regulatory procedure with scrutiny referred to in Article 32(3) of this Regulation within 15 months of the inclusion of the substances concerned in Part 3 of Annex VI to Regulation (EC) No 1272/2008.
On imperative grounds of urgency, the Commission may use the urgency procedure referred to in Article 32(4) of this Regulation.
The Commission shall mandate the SCCS to re-evaluate those substances as soon as safety concerns arise, and at the latest five years after their inclusion in Annexes III to VI to this Regulation, and at least every subsequent five years.
Article 16
Nanomaterials
In addition to the notification under Article 13, cosmetic products containing nanomaterials shall be notified to the Commission by the responsible person by electronic means six months prior to being placed on the market, except where they have already been placed on the market by the same responsible person before 11 January 2013.
In the latter case, cosmetic products containing nanomaterials placed on the market shall be notified to the Commission by the responsible person between 11 January 2013 and 11 July 2013 by electronic means, in addition to the notification in Article 13.
The first and the second subparagraphs shall not apply to cosmetic products containing nanomaterials that are in conformity with the requirements set out in Annex III.
The information notified to the Commission shall contain at least the following:
the identification of the nanomaterial including its chemical name (IUPAC) and other descriptors as specified in point 2 of the Preamble to Annexes II to VI;
the specification of the nanomaterial including size of particles, physical and chemical properties;
an estimate of the quantity of nanomaterial contained in cosmetic products intended to be placed on the market per year;
the toxicological profile of the nanomaterial;
the safety data of the nanomaterial relating to the category of cosmetic product, as used in such products;
the reasonably foreseeable exposure conditions.
The responsible person may designate another legal or natural person by written mandate for the notification of nanomaterials and shall inform the Commission thereof.
The Commission shall provide a reference number for the submission of the toxicological profile, which may substitute the information to be notified under point (d).
The following information shall be made available by the Commission:
By 11 January 2014, the Commission shall make available a catalogue of all nanomaterials used in cosmetic products placed on the market, including those used as colorants, UV-filters and preservatives in a separate section, indicating the categories of cosmetic products and the reasonably foreseeable exposure conditions. This catalogue shall be regularly updated thereafter and be made publicly available.
The Commission shall submit to the European Parliament and the Council an annual status report, which will give information on developments in the use of nanomaterials in cosmetic products within the Community, including those used as colorants, UV-filters and preservatives in a separate section. The first report shall be presented by 11 July 2014 The report update shall summarise, in particular, the new nanomaterials in new categories of cosmetic products, the number of notifications, the progress made in developing nano-specific assessment methods and safety assessment guides, and information on international cooperation programmes.
The Commission shall regularly review the provisions of this Regulation concerning nanomaterials in the light of scientific progress and shall, where necessary, propose suitable amendments to those provisions.
The first review shall be undertaken by 11 July 2018.
Article 17
Traces of prohibited substances
The non-intended presence of a small quantity of a prohibited substance, stemming from impurities of natural or synthetic ingredients, the manufacturing process, storage, migration from packaging, which is technically unavoidable in good manufacturing practice, shall be permitted provided that such presence is in conformity with Article 3.
CHAPTER V
ANIMAL TESTING
Article 18
Animal testing
Without prejudice to the general obligations deriving from Article 3, the following shall be prohibited:
the placing on the market of cosmetic products where the final formulation, in order to meet the requirements of this Regulation, has been the subject of animal testing using a method other than an alternative method after such alternative method has been validated and adopted at Community level with due regard to the development of validation within the OECD;
the placing on the market of cosmetic products containing ingredients or combinations of ingredients which, in order to meet the requirements of this Regulation, have been the subject of animal testing using a method other than an alternative method after such alternative method has been validated and adopted at Community level with due regard to the development of validation within the OECD;
the performance within the Community of animal testing of finished cosmetic products in order to meet the requirements of this Regulation;
the performance within the Community of animal testing of ingredients or combinations of ingredients in order to meet the requirements of this Regulation, after the date on which such tests are required to be replaced by one or more validated alternative methods listed in Commission Regulation (EC) No 440/2008 of 30 May 2008 laying down test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) ( 3 ) or in Annex VIII to this Regulation.
The Commission, after consulting the SCCS and the European Centre for the Validation of Alternative Methods (ECVAM) and with due regard to the development of validation within the OECD, has established timetables for the implementation of the provisions under points (a), (b) and (d) of paragraph 1, including deadlines for the phasing-out of the various tests. The timetables were made available to the public on 1 October 2004 and sent to the European Parliament and the Council. The period for implementation was limited to 11 March 2009 in relation to points (a), (b) and (d) of paragraph 1.
In relation to the tests concerning repeated-dose toxicity, reproductive toxicity and toxicokinetics, for which there are no alternatives yet under consideration, the period for implementation of paragraph 1(a) and (b) shall be limited to 11 March 2013.
The Commission shall study possible technical difficulties in complying with the ban in relation to tests, in particular those concerning repeated-dose toxicity, reproductive toxicity and toxicokinetics, for which there are no alternatives yet under consideration. Information about the provisional and final results of these studies forms part of the yearly reports presented pursuant to Article 35.
On the basis of these annual reports, the timetables established as referred to in the first subparagraph, could be adapted up to 11 March 2009 in relation to the first subparagraph and may be adapted up to 11 March 2013 in relation to the second subparagraph and after consultation of the entities referred to in the first subparagraph.
The Commission shall study progress and compliance with the deadlines as well as possible technical difficulties in complying with the ban. Information about the provisional and final results of the Commission studies forms part of the yearly reports presented pursuant to Article 35. If these studies conclude, at the latest two years prior to the end of the maximum period referred to in the second subparagraph, that for technical reasons one or more tests referred to in that subparagraph will not be developed and validated before the expiry of the period referred to therein it shall inform the European Parliament and the Council and shall put forward a legislative proposal in accordance with Article 251 of the Treaty.
In exceptional circumstances, where serious concerns arise as regards the safety of an existing cosmetic ingredient, a Member State may request the Commission to grant a derogation from paragraph 1. The request shall contain an evaluation of the situation and indicate the measures necessary. On this basis, the Commission may, after consulting the SCCS and by means of a reasoned decision, authorise the derogation. That authorisation shall lay down the conditions associated with this derogation in terms of specific objectives, duration and reporting of the results.
A derogation shall be granted only where:
the ingredient is in wide use and cannot be replaced by another ingredient capable of performing a similar function;
the specific human health problem is substantiated and the need to conduct animal tests is justified and is supported by a detailed research protocol proposed as the basis for the evaluation.
The decision on the authorisation, the conditions associated with it and the final result achieved shall be part of the annual report presented by the Commission in accordance with Article 35.
The measures referred to in the sixth subparagraph, designed to amend non-essential elements of this Regulation, shall be adopted in accordance with the regulatory procedure with scrutiny referred to in Article 32(3).
For the purposes of this Article and Article 20:
‘finished cosmetic product’ means the cosmetic product in its final formulation, as placed on the market and made available to the end user, or its prototype;
‘prototype’ means a first model or design that has not been produced in batches, and from which the finished cosmetic product is copied or finally developed.
CHAPTER VI
CONSUMER INFORMATION
Article 19
Labelling
Without prejudice to other provisions in this Article, cosmetic products shall be made available on the market only where the container and packaging of cosmetic products bear the following information in indelible, easily legible and visible lettering:
the name or registered name and the address of the responsible person. Such information may be abbreviated in so far as the abbreviation makes it possible to identify that person and his address. If several addresses are indicated, the one where the responsible person makes readily available the product information file shall be highlighted. The country of origin shall be specified for imported cosmetic products;
the nominal content at the time of packaging, given by weight or by volume, except in the case of packaging containing less than five grams or five millilitres, free samples and single-application packs; for pre-packages normally sold as a number of items, for which details of weight or volume are not significant, the content need not be given provided the number of items appears on the packaging. This information need not be given if the number of items is easy to see from the outside or if the product is normally only sold individually;
the date until which the cosmetic product, stored under appropriate conditions, will continue to fulfil its initial function and, in particular, will remain in conformity with Article 3 (‘date of minimum durability’).
The date itself or details of where it appears on the packaging shall be preceded by the symbol shown in point 3 of Annex VII or the words: ‘best used before the end of’.
The date of minimum durability shall be clearly expressed and shall consist of either the month and year or the day, month and year, in that order. If necessary, this information shall be supplemented by an indication of the conditions which must be satisfied to guarantee the stated durability.
Indication of the date of minimum durability shall not be mandatory for cosmetic products with a minimum durability of more than 30 months. For such products, there shall be an indication of the period of time after opening for which the product is safe and can be used without any harm to the consumer. This information shall be indicated, except where the concept of durability after opening is not relevant, by the symbol shown in point 2 of Annex VII followed by the period (in months and/or years);
particular precautions to be observed in use, and at least those listed in Annexes III to VI and any special precautionary information on cosmetic products for professional use;
the batch number of manufacture or the reference for identifying the cosmetic product. Where this is impossible for practical reasons because the cosmetic products are too small, such information need appear only on the packaging;
the function of the cosmetic product, unless it is clear from its presentation;
a list of ingredients. This information may be indicated on the packaging alone. The list shall be preceded by the term ‘ingredients’.
For the purpose of this Article, an ingredient means any substance or mixture intentionally used in the cosmetic product during the process of manufacturing. The following shall not, however, be regarded as ingredients:
impurities in the raw materials used;
subsidiary technical materials used in the mixture but not present in the final product.
Perfume and aromatic compositions and their raw materials shall be referred to by the terms ‘parfum’ or ‘aroma’. Moreover, the presence of substances, the mention of which is required under the column ‘Other’ in Annex III, shall be indicated in the list of ingredients in addition to the terms parfum or aroma.
The list of ingredients shall be established in descending order of weight of the ingredients at the time they are added to the cosmetic product. Ingredients in concentrations of less than 1 % may be listed in any order after those in concentrations of more than 1 %.
All ingredients present in the form of nanomaterials shall be clearly indicated in the list of ingredients. The names of such ingredients shall be followed by the word ‘nano’ in brackets.
Colorants other than colorants intended to colour the hair may be listed in any order after the other cosmetic ingredients. For decorative cosmetic products marketed in several colour shades, all colorants other than colorants intended to colour the hair used in the range may be listed, provided that the words ‘may contain’ or the symbol ‘+/-’ are added. The CI (Colour Index) nomenclature shall be used, where applicable.
Where it is impossible for practical reasons to label the information mentioned in points (d) and (g) of paragraph 1 as provided, the following applies:
Article 20
Product claims
The Commission shall, in cooperation with Member States, establish an action plan regarding claims used and fix priorities for determining common criteria justifying the use of a claim.
After consulting the SCCS or other relevant authorities, the Commission shall adopt a list of common criteria for claims which may be used in respect of cosmetic products, in accordance with the regulatory procedure with scrutiny referred to in Article 32(3) of this Regulation, taking into account the provisions of Directive 2005/29/EC.
By 11 July 2016, the Commission shall submit to the European Parliament and the Council a report regarding the use of claims on the basis of the common criteria adopted under the second subparagraph. If the report concludes that claims used in respect of cosmetic products are not in conformity with the common criteria, the Commission shall take appropriate measures to ensure compliance in cooperation with the Member States.
Article 21
Access to information for the public
Without prejudice to the protection, in particular, of commercial secrecy and of intellectual property rights, the responsible person shall ensure that the qualitative and quantitative composition of the cosmetic product and, in the case of perfume and aromatic compositions, the name and code number of the composition and the identity of the supplier, as well as existing data on undesirable effects and serious undesirable effects resulting from use of the cosmetic product are made easily accessible to the public by any appropriate means.
The quantitative information regarding composition of the cosmetic product required to be made publicly accessible shall be limited to hazardous substances in accordance with Article 3 of Regulation (EC) No 1272/2008.
CHAPTER VII
MARKET SURVEILLANCE
Article 22
In-market control
Member States shall monitor compliance with this Regulation via in-market controls of the cosmetic products made available on the market. They shall perform appropriate checks of cosmetic products and checks on the economic operators on an adequate scale, through the product information file and, where appropriate, physical and laboratory checks on the basis of adequate samples.
Member States shall also monitor compliance with the principles of good manufacturing practices.
Member States shall entrust to market surveillance authorities the necessary powers, resources and knowledge in order for those authorities to properly perform their tasks.
Member States shall periodically review and assess the functioning of their surveillance activities. Such reviews and assessments shall be carried out at least every four years and the results thereof shall be communicated to the other Member States and the Commission and be made available to the public, by way of electronic communication and, where appropriate, by other means.
Article 23
Communication of serious undesirable effects
In the event of serious undesirable effects, the responsible person and distributors shall without delay notify the following to the competent authority of the Member State where the serious undesirable effect occurred:
all serious undesirable effects which are known to him or which may reasonably be expected to be known to him;
the name of the cosmetic product concerned, enabling its specific identification;
the corrective measures taken by him, if any.
Article 24
Information on substances
In the event of serious doubt regarding the safety of any substance contained in cosmetic products, the competent authority of a Member State in which a product containing such a substance is made available on the market may by reasoned request require the responsible person to submit a list of all cosmetic products for which he is responsible and which contain this substance. The list shall indicate the concentration of this substance in the cosmetic products.
Competent authorities may use the information referred to in this Article for the purposes of in-market surveillance, market analysis, evaluation and consumer information in the context of Articles 25, 26 and 27.
CHAPTER VIII
NON-COMPLIANCE, SAFEGUARD CLAUSE
Article 25
Non-compliance by the responsible person
Without prejudice to paragraph 4, competent authorities shall require the responsible person to take all appropriate measures, including corrective actions bringing the cosmetic product into conformity, the withdrawal of the product from the market or its recall, within an expressly mentioned time limit, commensurate with the nature of the risk, where there is non-compliance with any of the following:
the good manufacturing practice referred to in Article 8;
the safety assessment referred to in Article 10;
the requirements for the product information file referred to in Article 11;
the provisions on sampling and analysis referred to in Article 12;
the notification requirements referred to in Articles 13 and 16;
the restrictions for substances referred to in Articles 14, 15 and 17;
the animal testing requirements referred to in Article 18;
the labelling requirements referred to in Article 19(1), (2), (5) and (6);
the requirements related to product claims set out in Article 20;
the access to information for the public referred to in Article 21;
the communication of serious undesirable effects referred to in Article 23;
the information requirements on substances referred to in Article 24.
The competent authority shall take all appropriate measures to prohibit or restrict the making available on the market of the cosmetic product or to withdraw the product from the market or to recall it in the following cases:
where an immediate action is necessary in the event of serious risk to human health; or
where the responsible person does not take all appropriate measures within the time limit referred to in paragraph 1.
In the event of serious risks to human health, that competent authority shall inform the Commission and the competent authorities of the other Member States, without delay, of the measures taken.
For the purposes of paragraphs 4 and 5 of this Article, the information exchange system provided for in Article 12(1) of Directive 2001/95/EC of the European Parliament and of the Council of 3 December 2001 on general product safety ( 4 ) shall be used.
Article 12(2), (3) and (4) of Directive 2001/95/EC and Article 23 of Regulation (EC) No 765/2008 of the European Parliament and of the Council of 9 July 2008 setting out the requirements for accreditation and market surveillance relating to the marketing of products ( 5 ) shall also apply.
Article 26
Non-compliance by distributors
Competent authorities shall require distributors to take all appropriate measures, including corrective actions bringing the cosmetic product into conformity, the withdrawal of the product from the market or its recall, within a given reasonable time limit, commensurate with the nature of the risk, where there is non-compliance with obligations laid down in Article 6.
Article 27
Safeguard clause
The competent authority shall immediately communicate to the Commission and the competent authorities of the other Member States the measures taken and any supporting data.
For the purposes of the first subparagraph, the information exchange system provided for in Article 12(1) of Directive 2001/95/EC shall be used.
Article 12(2), (3) and (4) of Directive 2001/95/EC shall apply.
Article 28
Good administrative practices
CHAPTER IX
ADMINISTRATIVE COOPERATION
Article 29
Cooperation between competent authorities
Article 30
Cooperation regarding verification of product information files
The competent authority of any Member State where the cosmetic product is made available may request the competent authority of the Member State where the product information file is made readily accessible to verify whether the product information file satisfies the requirements referred to in Article 11(2) and whether the information set out therein provides evidence of the safety of the cosmetic product.
The requesting competent authority shall provide a motivation for the request.
Upon that request, the competent authority requested shall, without undue delay and taking into account the degree of urgency, carry out the verification and shall inform the requesting competent authority of its findings.
CHAPTER X
IMPLEMENTING MEASURES, FINAL PROVISIONS
Article 31
Amendment of the Annexes
Where there is a potential risk to human health, arising from the use of substances in cosmetic products, which needs to be addressed on a Community-wide basis, the Commission may, after consulting the SCCS, amend Annexes II to VI accordingly.
Those measures, designed to amend non-essential elements of this Regulation, shall be adopted in accordance with the regulatory procedure with scrutiny referred to in Article 32(3).
On imperative grounds of urgency, the Commission may use the urgency procedure referred to in Article 32(4).
The Commission may, after consulting the SCCS, amend Annexes III to VI and VIII for the purposes of adapting them to technical and scientific progress.
Those measures, designed to amend non-essential elements of this Regulation, shall be adopted in accordance with the regulatory procedure with scrutiny referred to in Article 32(3).
Where it appears necessary, in order to ensure the safety of cosmetic products placed on the market, the Commission may, after consulting the SCCS, amend Annex I.
Those measures, designed to amend non-essential elements of this Regulation, shall be adopted in accordance with the regulatory procedure with scrutiny referred to in Article 32(3).
Article 32
Committee procedure
Where reference is made to this paragraph, Articles 5 and 7 of Decision 1999/468/EC shall apply, having regard to the provisions of Article 8 thereof.
The period laid down in Article 5(6) of Decision 1999/468/EC shall be set at three months.
Article 33
Glossary of common ingredient names
The Commission shall compile and update a glossary of common ingredient names. To this end, the Commission shall take account of internationally recognised nomenclatures including the International Nomenclature of Cosmetic Ingredients (INCI). That glossary shall not constitute a list of the substances authorised for use in cosmetic products.
The common ingredient name shall be applied for the purpose of labelling cosmetic products placed on the market at the latest twelve months after publication of the glossary in the Official Journal of the European Union.
Article 34
Competent authorities, poison control centres or assimilated entities
Article 35
Annual report on animal testing
Every year the Commission shall present a report to the European Parliament and the Council on:
progress made in the development, validation and legal acceptance of alternative methods. The report shall contain precise data on the number and type of experiments relating to cosmetic products carried out on animals. The Member States shall be obliged to collect that information in addition to collecting statistics as laid down by Directive 86/609/EEC. The Commission shall in particular ensure the development, validation and legal acceptance of alternative test methods which do not use live animals;
progress made by the Commission in its efforts to obtain acceptance by the OECD of alternative methods validated at Community level and recognition by third countries of the results of the safety tests carried out in the Community using alternative methods, in particular within the framework of cooperation agreements between the Community and these countries;
the manner in which the specific needs of small and medium-sized enterprises have been taken into account.
Article 36
Formal objection against harmonised standards
Article 37
Penalties
Member States shall lay down the provisions on penalties applicable for infringement of the provisions of this Regulation and shall take all measures necessary to ensure that they are implemented. The penalties provided for must be effective, proportionate and dissuasive. The Member States shall notify those provisions to the Commission by 11 July 2013 and shall notify it without delay of any subsequent amendment affecting them.
Article 38
Repeal
Directive 76/768/EEC is repealed with effect from 11 July 2013, with the exception of Article 4b which is repealed with effect from 1 December 2010.
References to the repealed Directive shall be understood as references to this Regulation.
This Regulation shall be without prejudice to the obligations of the Member States relating to the time-limits for transposition into national law of the Directives set out in Part B of Annex IX.
However, the competent authorities shall continue to keep available the information received pursuant to Article 7(3) and Article 7a(4) of Directive 76/768/EEC and responsible persons shall continue to keep readily accessible the information collected pursuant to Article 7a of that Directive until 11 July 2020.
Article 39
Transitional provisions
By way of derogation from Directive 76/768/EEC, cosmetic products which comply with this Regulation may be placed on the market before 11 July 2013.
As from 11 January 2012, by way of derogation from Directive 76/768/EEC, notification carried out in accordance with Article 13 of this Regulation shall be considered to comply with Article 7(3) and Article 7a(4) of that Directive.
Article 40
Entry into force and date of application
It shall apply from 11 July 2013, with the exception of:
This Regulation shall be binding in its entirety and directly applicable in all Member States.
ANNEX I
COSMETIC PRODUCT SAFETY REPORT
The cosmetic product safety report shall, as a minimum, contain the following:
PART A – Cosmetic product safety information
1. Quantitative and qualitative composition of the cosmetic product
The qualitative and quantitative composition of the cosmetic product, including chemical identity of the substances (incl. chemical name, INCI, CAS, EINECS/ELINCS, where possible) and their intended function. In the case of perfume and aromatic compositions, description of the name and code number of the composition and the identity of the supplier.
2. Physical/chěmical characteristics and stability of the cosmetic product
The physical and chemical characteristics of the substances or mixtures, as well as the cosmetic product.
The stability of the cosmetics product under reasonably foreseeable storage conditions.
3. Microbiological quality
The microbiological specifications of the substance or mixture and the cosmetic product. Particular attention shall be paid to cosmetics used around the eyes, on mucous membranes in general, on damaged skin, on children under three years of age, on elderly people and persons showing compromised immune responses.
Results of preservation challenge test.
4. Impurities, traces, information about the packaging material
The purity of the substances and mixtures.
In the case of traces of prohibited substances, evidence for their technical unavoidability.
The relevant characteristics of packaging material, in particular purity and stability.
5. Normal and reasonably foreseeable use
The normal and reasonably foreseeable use of the product. The reasoning shall be justified in particular in the light of warnings and other explanations in the product labelling.
6. Exposure to the cosmetic product
Data on the exposure to cosmetic product taking into consideration the findings under Section 5 in relation to
The site(s) of application;
The surface area(s) of application;
The amount of product applied;
The duration and frequency of use;
The normal and reasonably foreseeable exposure route(s);
The targeted (or exposed) population(s). Potential exposure of a specific population shall also be taken into account.
The calculation of the exposure shall also take into consideration the toxicological effects to be considered (e.g. exposure might need to be calculated per unit area of skin or per unit of body weight). The possibility of secondary exposure by routes other than those resulting from direct application should also be considered (e.g. non-intended inhalation of sprays, non-intended ingestion of lip products, etc.).
Particular consideration shall be given to any possible impacts on exposure due to particle sizes.
7. Exposure to the substances
Data on the exposure to the substances contained in the cosmetic product for the relevant toxicological endpoints taking into account the information under Section 6.
8. Toxicological profile of the substances
Without prejudice to Article 18, the toxicological profile of substance contained in the cosmetic product for all relevant toxicological endpoints. A particular focus on local toxicity evaluation (skin and eye irritation), skin sensitisation, and in the case of UV absorption photo-induced toxicity shall be made.
All significant toxicological routes of absorption shall be considered as well as the systemic effects and margin of safety (MoS) based on a no observed adverse effects level (NOAEL) shall be calculated. The absence of these considerations shall be duly justified.
Particular consideration shall be given to any possible impacts on the toxicological profile due to
Any read-across shall be duly substantiated and justified.
The source of information shall be clearly identified.
9. Undesirable effects and serious undesirable effects
All available data on the undesirable effects and serious undesirable effects to the cosmetic product or, where relevant, other cosmetic products. This includes statistical data.
10. Information on the cosmetic product
Other relevant information, e.g. existing studies from human volunteers or the duly confirmed and substantiated findings of risk assessments carried out in other relevant areas.
PART B – Cosmetic product safety assessment
1. Assessment conclusion
Statement on the safety of the cosmetic product in relation to Article 3.
2. Labelled warnings and instructions of use
Statement on the need to label any particular warnings and instructions of use in accordance with Article 19(1)(d).
3. Reasoning
Explanation of the scientific reasoning leading to the assessment conclusion set out under Section 1 and the statement set out under Section 2. This explanation shall be based on the descriptions set out under Part A. Where relevant, margins of safety shall be assessed and discussed.
There shall be inter alia a specific assessment for cosmetic products intended for use on children under the age of three and for cosmetic products intended exclusively for use in external intimate hygiene.
Possible interactions of the substances contained in the cosmetic product shall be assessed.
The consideration and non-consideration of the different toxicological profiles shall be duly justified.
Impacts of the stability on the safety of the cosmetic product shall be duly considered.
4. Assessor's credentials and approval of part B
Name and address of the safety assessor.
Proof of qualification of safety assessor.
Date and signature of safety assessor.
Preamble to Annexes II to VI
For the purposes of the Annexes II to VI:
‘Rinse-off product’ means a cosmetic product which is intended to be removed after application on the skin, the hair or the mucous membranes;
‘Leave-on product’ means a cosmetic product which is intended to stay in prolonged contact with the skin, the hair or the mucous membranes;
‘Hair product’ means a cosmetic product which is intended to be applied on the hair of head or face, except eye lashes;
‘Skin product’ means a cosmetic product which is intended to be applied on the skin;
‘Lip product’ means a cosmetic product which is intended to be applied on the lips;
‘Face product’ means a cosmetic product which is intended to be applied on the skin of the face;
‘Nail product’ means a cosmetic product which is intended to be applied on nails;
‘Oral product’ means a cosmetic product which is intended to be applied on teeth or the mucous membranes of the oral cavity;
‘Product applied on mucous membranes’ means a cosmetic product which is intended to be applied on the mucous membranes
‘Eye product’ means a cosmetic product which is intended to be applied in the vicinity of the eyes;
‘Professional use’ means the application and use of cosmetic products by persons in the exercise of their professional activity.
In order to facilitate substance identification, the following descriptors are used:
Substances listed in Annexes III to VI do not cover nanomaterials, except where specifically mentioned.
ANNEX II
LIST OF SUBSTANCES PROHIBITED IN COSMETIC PRODUCTS
|
Reference number |
Substance identification |
||
|
Chemical name/INN |
CAS number |
EC number |
|
|
a |
b |
c |
d |
|
1 |
N-(5-Chlorobenzoxazol-2-yl)acetamide |
35783-57-4 |
|
|
2 |
(2-Acetoxyethyl)trimethylammonium hydroxide (Acetylcholine) and its salts |
51-84-3 |
200-128-9 |
|
3 |
Deanol aceglumate (INN) |
3342-61-8 |
222-085-5 |
|
4 |
Spironolactone (INN) |
52-01-7 |
200-133-6 |
|
5 |
[4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid (Tiratricol (INN)) and its salts |
51-24-1 |
200-086-1 |
|
6 |
Methotrexate (INN) |
59-05-2 |
200-413-8 |
|
7 |
Aminocaproic acid (INN) and its salts |
60-32-2 |
200-469-3 |
|
8 |
Cinchophen (INN), its salts, derivatives and salts of these derivatives |
132-60-5 |
205-067-1 |
|
9 |
Thyropropic acid (INN) and its salts |
51-26-3 |
|
|
10 |
Trichloroacetic acid |
76-03-9 |
200-927-2 |
|
11 |
Aconitum napellus L. (leaves, roots and galenical preparations) |
84603-50-9 |
283-252-6 |
|
12 |
Aconitine (principal alkaloid of Aconitum napellus L.) and its salts |
302-27-2 |
206-121-7 |
|
13 |
Adonis vernalis L. and its preparations |
84649-73-0 |
283-458-6 |
|
14 |
Epinephrine (INN) |
51-43-4 |
200-098-7 |
|
15 |
Rauwolfia serpentina L., alkaloids and their salts |
90106-13-1 |
290-234-1 |
|
16 |
Alkyne alcohols, their esters, ethers and salts |
|
|
|
17 |
Isoprenaline (INN) |
7683-59-2 |
231-687-7 |
|
18 |
Allyl isothiocyanate |
57-06-7 |
200-309-2 |
|
19 |
Alloclamide (INN) and its salts |
5486-77-1 |
|
|
20 |
Nalorphine (INN), its salts and ethers |
62-67-9 |
200-546-1 |
|
21 |
Sympathicomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and are referred to in resolution AP (69) 2 of the Council of Europe |
300-62-9 |
206-096-2 |
|
22 |
Aniline, its salts and its halogenated and sulphonated derivatives |
62-53-3 |
200-539-3 |
|
23 |
Betoxycaine (INN) and its salts |
3818-62-0 |
|
|
24 |
Zoxazolamine (INN) |
61-80-3 |
200-519-4 |
|
25 |
Procainamide (INN), its salts and derivatives |
51-06-9 |
200-078-8 |
|
26 |
Benzidine |
92-87-5 |
202-199-1 |
|
27 |
Tuaminoheptane (INN), its isomers and salts |
123-82-0 |
204-655-5 |
|
28 |
Octodrine (INN) and its salts |
543-82-8 |
208-851-1 |
|
29 |
2-Amino-1,2-bis(4-methoxyphenyl)ethanol and its salts |
530-34-7 |
|
|
30 |
1,3-Dimethylpentylamine and its salts |
105-41-9 |
203-296-1 |
|
31 |
4-Aminosalicylic acid and its salts |
65-49-6 |
200-613-5 |
|
32 |
Toluidines, their isomers, salts and halogenated and sulphonated derivatives |
26915-12-8 |
248-105-2 |
|
33 |
Xylidines, their isomers, salts and halogenated and sulphonated derivatives |
1300-73-8 |
215-091-4 |
|
34 |
Imperatorin (9-(3-methylbut-2-enyloxy)furo[3,2-g]chromen-7-one) |
482-44-0 |
207-581-1 |
|
35 |
Ammi majus L. and its galenical preparations |
90320-46-0 |
291-072-4 |
|
36 |
2,3-Dichloro-2-methylbutane |
507-45-9 |
|
|
37 |
Substances with androgenic effect |
|
|
|
38 |
Anthracene oil |
120-12-7 |
204-371-1 |
|
39 |
Antibiotics |
|
|
|
40 |
Antimony and its compounds |
7440-36-0 |
231-146-5 |
|
41 |
Apocynum cannabinum L. and its preparations |
84603-51-0 |
283-253-1 |
|
42 |
Apomorphine ((R) 5,6,6a,7-tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol) and its salts |
58-00-4 |
200-360-0 |
|
43 |
Arsenic and its compounds |
7440-38-2 |
231-148-6 |
|
44 |
Atropa belladonna L. and its preparations |
8007-93-0 |
232-365-9 |
|
45 |
Atropine, its salts and derivatives |
51-55-8 |
200-104-8 |
|
46 |
Barium salts, with the exception of barium sulphide under the conditions laid down in Annex III, and of barium sulfate, lakes, salts and pigments prepared from colouring agents when listed in Annex IV |
|
|
|
47 |
Benzene |
71-43-2 |
200-753-7 |
|
48 |
Benzimidazol-2(3H)-one |
615-16-7 |
210-412-4 |
|
49 |
Benzazepines and benzodiazepines |
12794-10-4 |
|
|
50 |
1-Dimethylaminomethyl-1-methylpropyl benzoate (amylocaine) and its salts |
644-26-8 |
211-411-1 |
|
51 |
2,2,6-Trimethyl-4-piperidyl benzoate (eucaine) and its salts |
500-34-5 |
|
|
52 |
Isocarboxazid (INN) |
59-63-2 |
200-438-4 |
|
53 |
Bendroflumethiazide (INN) and its derivatives |
73-48-3 |
200-800-1 |
|
54 |
Beryllium and its compounds |
7440-41-7 |
231-150-7 |
|
55 |
Bromine, elemental |
7726-95-6 |
231-778-1 |
|
56 |
Bretylium tosilate (INN) |
61-75-6 |
200-516-8 |
|
57 |
Carbromal (INN) |
77-65-6 |
201-046-6 |
|
58 |
Bromisoval (INN) |
496-67-3 |
207-825-7 |
|
59 |
Brompheniramine (INN) and its salts |
86-22-6 |
201-657-8 |
|
60 |
Benzilonium bromide (INN) |
1050-48-2 |
213-885-5 |
|
61 |
Tetrylammonium bromide (INN) |
71-91-0 |
200-769-4 |
|
62 |
Brucine |
357-57-3 |
206-614-7 |
|
63 |
Tetracaine (INN) and its salts |
94-24-6 |
202-316-6 |
|
64 |
Mofebutazone (INN) |
2210-63-1 |
218-641-1 |
|
65 |
Tolbutamide (INN) |
64-77-7 |
200-594-3 |
|
66 |
Carbutamide (INN) |
339-43-5 |
206-424-4 |
|
67 |
Phenylbutazone (INN) |
50-33-9 |
200-029-0 |
|
68 |
Cadmium and its compounds |
7440-43-9 |
231-152-8 |
|
69 |
Cantharides, Cantharis vesicatoria |
92457-17-5 |
296-298-7 |
|
70 |
Cantharidine |
56-25-7 |
200-263-3 |
|
71 |
Phenprobamate (INN) |
673-31-4 |
211-606-1 |
|
72 |
Nitroderivatives of carbazole |
|
|
|
73 |
Carbon disulphide |
75-15-0 |
200-843-6 |
|
74 |
Catalase |
9001-05-2 |
232-577-1 |
|
75 |
Cephaeline and its salts |
483-17-0 |
207-591-6 |
|
76 |
Chenopodium ambrosioides L. (essential oil) |
8006-99-3 |
|
|
77 |
2,2,2-Trichloroethane-1,1-diol |
302-17-0 |
206-117-5 |
|
78 |
Chlorine |
7782-50-5 |
231-959-5 |
|
79 |
Chlorpropamide (INN) |
94-20-2 |
202-314-5 |
|
80 |
Moved or deleted |
|
|
|
81 |
4-Phenylazophenylene-1,3-diamine citrate hydrochloride (chrysoidine citrate hydrochloride) |
5909-04-6 |
|
|
82 |
Chlorzoxazone (INN) |
95-25-0 |
202-403-9 |
|
83 |
2-Chloro-6-methylpyrimidin-4-yldimethylamine (crimidine-ISO) |
535-89-7 |
208-622-6 |
|
84 |
Chlorprothixene (INN) and its salts |
113-59-7 |
204-032-8 |
|
85 |
Clofenamide (INN) |
671-95-4 |
211-588-5 |
|
86 |
N,N-bis(2-chloroethyl)methylamine N-oxide and its salts |
126-85-2 |
|
|
87 |
Chlormethine (INN) and its salts |
51-75-2 |
200-120-5 |
|
88 |
Cyclophosphamide (INN) and its salts |
50-18-0 |
200-015-4 |
|
89 |
Mannomustine (INN) and its salts |
576-68-1 |
209-404-3 |
|
90 |
Butanilicaine (INN) and its salts |
3785-21-5 |
|
|
91 |
Chlormezanone (INN) |
80-77-3 |
201-307-4 |
|
92 |
Triparanol (INN) |
78-41-1 |
201-115-0 |
|
93 |
2-[2(4-Chlorophenyl)-2-phenylacetyl]indane-1,3-dione (chlorophacinone-ISO) |
3691-35-8 |
223-003-0 |
|
94 |
Chlorphenoxamine (INN) |
77-38-3 |
|
|
95 |
Phenaglycodol (INN) |
79-93-6 |
201-235-3 |
|
96 |
Chloroethane |
75-00-3 |
200-830-5 |
|
97 |
Chromium; chromic acid and its salts |
7440-47-3 |
231-157-5 |
|
98 |
Claviceps purpurea Tul., its alkaloids and galenical preparations |
84775-56-4 |
283-885-8 |
|
99 |
Conium maculatum L. (fruit, powder, galenical preparations) |
85116-75-2 |
285-527-6 |
|
100 |
Glycyclamide (INN) |
664-95-9 |
211-557-6 |
|
101 |
Cobalt benzenesulphonate |
23384-69-2 |
|
|
102 |
Colchicine, its salts and derivatives |
64-86-8 |
200-598-5 |
|
103 |
Colchicoside and its derivatives |
477-29-2 |
207-513-0 |
|
104 |
Colchicum autumnale L. and its galenical preparations |
84696-03-7 |
283-623-2 |
|
105 |
Convallatoxin |
508-75-8 |
208-086-3 |
|
106 |
Anamirta cocculus L. (fruit) |
|
|
|
107 |
Croton tiglium L. (oil) |
8001-28-3 |
|
|
108 |
1-Butyl-3-(N-crotonoylsulphanilyl)urea |
52964-42-8 |
|
|
109 |
Curare and curarine |
8063-06-7/22260-42-0 |
232-511-1/244-880-6 |
|
110 |
Synthetic curarizants |
|
|
|
111 |
Hydrogen cyanide and its salts |
74-90-8 |
200-821-6 |
|
112 |
Feclemine (INN); 2-(alpha-Cyclohexylbenzyl)-N,N,N',N'-tetraethyl-1,3-propanediamine |
3590-16-7 |
|
|
113 |
Cyclomenol (INN) and its salts |
5591-47-9 |
227-002-6 |
|
114 |
Sodium hexacyclonate (INN) |
7009-49-6 |
|
|
115 |
Hexapropymate (INN) |
358-52-1 |
206-618-9 |
|
116 |
Moved or deleted |
|
|
|
117 |
O,O'-Diacetyl-N-allyl-N-normorphine |
2748-74-5 |
|
|
118 |
Pipazetate (INN) and its salts |
2167-85-3 |
218-508-8 |
|
119 |
5-(α,β-Dibromophenethyl)-5-methylhydantoin |
511-75-1 |
208-133-8 |
|
120 |
N,N'-Pentamethylenebis(trimethylammonium) salts, e. g. pentamethonium bromide (INN) |
541-20-8 |
208-771-7 |
|
121 |
N,N'-[(Methylimino)diethylene]bis(ethyldimethylammonium) salts, e. g. azamethonium bromide (INN) |
306-53-6 |
206-186-1 |
|
122 |
Cyclarbamate (INN) |
5779-54-4 |
227-302-7 |
|
123 |
Clofenotane (INN); DDT (ISO) |
50-29-3 |
200-024-3 |
|
124 |
N,N'-Hexamethylenebis(trimethylammonium) salts, e. g. hexamethonium bromide (INN) |
55-97-0 |
200-249-7 |
|
125 |
Dichloroethanes (ethylene chlorides) e.g. 1,2-Dichloroethane |
107-06-2 |
203-458-1 |
|
126 |
Dichloroethylenes (acetylene chlorides) e.g. Vinylidene chloride (1,1-Dichloroethylene) |
75-35-4 |
200-864-0 |
|
127 |
Lysergide (INN) (LSD) and its salts |
50-37-3 |
200-033-2 |
|
128 |
2-Diethylaminoethyl 3-hydroxy-4-phenylbenzoate and its salts |
3572-52-9 |
222-686-2 |
|
129 |
Cinchocaine (INN) and its salts |
85-79-0 |
201-632-1 |
|
130 |
3-Diethylaminopropyl cinnamate |
538-66-9 |
|
|
131 |
O,O'-Diethyl-O-4-nitrophenyl phosphorothioate (Parathion - ISO) |
56-38-2 |
200-271-7 |
|
132 |
[Oxalylbis(iminoethylene)]bis[(o-chlorobenzyl)diethylammonium] salts, e. g. ambenonium chloride (INN) |
115-79-7 |
204-107-5 |
|
133 |
Methyprylon (INN) and its salts |
125-64-4 |
204-745-4 |
|
134 |
Digitaline and all heterosides of Digitalis purpurea L. |
752-61-4 |
212-036-6 |
|
135 |
7-[2-Hydroxy-3-(2-hydroxyethyl-N-methylamino)propyl]theophylline (xanthinol) |
2530-97-4 |
|
|
136 |
Dioxethedrin (INN) and its salts |
497-75-6 |
207-849-8 |
|
137 |
Piprocurarium iodide (INN) |
3562-55-8 |
222-627-0 |
|
138 |
Propyphenazone (INN) |
479-92-5 |
207-539-2 |
|
139 |
Tetrabenazine (INN) and its salts |
58-46-8 |
200-383-6 |
|
140 |
Captodiame (INN) |
486-17-9 |
207-629-1 |
|
141 |
Mefeclorazine (INN) and its salts |
1243-33-0 |
|
|
142 |
Dimethylamine |
124-40-3 |
204-697-4 |
|
143 |
1,1-Bis(dimethylaminomethyl)propyl benzoate (amydricaine, alypine) and its salts |
963-07-5 |
213-512-6 |
|
144 |
Methapyrilene (INN) and its salts |
91-80-5 |
202-099-8 |
|
145 |
Metamfepramone (INN) and its salts |
15351-09-4 |
239-384-1 |
|
146 |
Amitriptyline (INN) and its salts |
50-48-6 |
200-041-6 |
|
147 |
Metformin (INN) and its salts |
657-24-9 |
211-517-8 |
|
148 |
Isosorbide dinitrate (INN) |
87-33-2 |
201-740-9 |
|
149 |
Malononitrile |
109-77-3 |
203-703-2 |
|
150 |
Succinonitrile |
110-61-2 |
203-783-9 |
|
151 |
Dinitrophenol isomers |
51-28-5/329-71-5/573-56-8/25550-58-7 |
200-087-7/206-348-1/209-357-9/247-096-2 |
|
152 |
Inproquone (INN) |
436-40-8 |
|
|
153 |
Dimevamide (INN) and its salts |
60-46-8 |
200-479-8 |
|
154 |
Diphenylpyraline (INN) and its salts |
147-20-6 |
205-686-7 |
|
155 |
Sulfinpyrazone (INN) |
57-96-5 |
200-357-4 |
|
156 |
N-(3-Carbamoyl-3,3-diphenylpropyl)-N,N-diisopropylmethyl-ammonium salts, e. g. isopropamide iodide (INN) |
71-81-8 |
200-766-8 |
|
157 |
Benactyzine (INN) |
302-40-9 |
206-123-8 |
|
158 |
Benzatropine (INN) and its salts |
86-13-5 |
|
|
159 |
Cyclizine (INN) and its salts |
82-92-8 |
201-445-5 |
|
160 |
5,5-Diphenyl-4-imidazolidone (Doxenitoin (INN)) |
3254-93-1 |
221-851-6 |
|
161 |
Probenecid (INN) |
57-66-9 |
200-344-3 |
|
162 |
Disulfiram (INN); thiram (INN) |
97-77-8/137-26-8 |
202-607-8/205-286-2 |
|
163 |
Emetine, its salts and derivatives |
483-18-1 |
207-592-1 |
|
164 |
Ephedrine and its salts |
299-42-3 |
206-080-5 |
|
165 |
Oxanamide (INN) and its derivatives |
126-93-2 |
|
|
166 |
Eserine or physostigmine and its salts |
57-47-6 |
200-332-8 |
|
167 |
4-Aminobenzoic acid and its esters, with the free amino group |
150-13-0 |
205-753-0 |
|
168 |
Choline salts and their esters, e. g. choline chloride (INN) |
67-48-1 |
200-655-4 |
|
169 |
Caramiphen (INN) and its salts |
77-22-5 |
201-013-6 |
|
170 |
Diethyl 4-nitrophenyl phosphate (Paraoxon - ISO) |
311-45-5 |
206-221-0 |
|
171 |
Metethoheptazine (INN) and its salts |
509-84-2 |
|
|
172 |
Oxpheneridine (INN) and its salts |
546-32-7 |
|
|
173 |
Ethoheptazine (INN) and its salts |
77-15-6 |
201-007-3 |
|
174 |
Metheptazine (INN) and its salts |
469-78-3 |
|
|
175 |
Methylphenidate (INN) and its salts |
113-45-1 |
204-028-6 |
|
176 |
Doxylamine (INN) and its salts |
469-21-6 |
207-414-2 |
|
177 |
Tolboxane (INN) |
2430-46-8 |
|
|
178 |
4-Benzyloxyphenol and 4-ethoxyphenol |
103-16-2/622-62-8 |
203-083-3/210-748-1 |
|
179 |
Parethoxycaine (INN) and its salts |
94-23-5 |
205-246-4 |
|
180 |
Fenozolone (INN) |
15302-16-6 |
239-339-6 |
|
181 |
Glutethimide (INN) and its salts |
77-21-4 |
201-012-0 |
|
182 |
Ethylene oxide |
75-21-8 |
200-849-9 |
|
183 |
Bemegride (INN) and its salts |
64-65-3 |
200-588-0 |
|
184 |
Valnoctamide (INN) |
4171-13-5 |
224-033-7 |
|
185 |
Haloperidol (INN) |
52-86-8 |
200-155-6 |
|
186 |
Paramethasone (INN) |
53-33-8 |
200-169-2 |
|
187 |
Fluanisone (INN) |
1480-19-9 |
216-038-8 |
|
188 |
Trifluperidol (INN) |
749-13-3 |
|
|
189 |
Fluoresone (INN) |
2924-67-6 |
220-889-0 |
|
190 |
Fluorouracil (INN) |
51-21-8 |
200-085-6 |
|
191 |
Hydrofluoric acid, its normal salts, its complexes and hydrofluorides with the exception of those given in Annex III |
7664-39-3 |
231-634-8 |
|
192 |
Furfuryltrimethylammonium salts, e. g. furtrethonium iodide (INN) |
541-64-0 |
208-789-5 |
|
193 |
Galantamine (INN) |
357-70-0 |
|
|
194 |
Progestogens |
|
|
|
195 |
1,2,3,4,5,6-Hexachlorocyclohexane (BHC-ISO) |
58-89-9 |
200-401-2 |
|
196 |
(1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethano-naphthalene (endrin-ISO) |
72-20-8 |
200-775-7 |
|
197 |
Hexachloroethane |
67-72-1 |
200-666-4 |
|
198 |
(1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene (isodrin-ISO) |
465-73-6 |
207-366-2 |
|
199 |
Hydrastine, hydrastinine and their salts |
118-08-1/6592-85-4 |
204-233-0/229-533-9 |
|
200 |
Hydrazides and their salts e.g. Isoniazid (INN) |
54-85-3 |
200-214-6 |
|
201 |
Hydrazine, its derivatives and their salts |
302-01-2 |
206-114-9 |
|
202 |
Octamoxin (INN) and its salts |
4684-87-1 |
|
|
203 |
Warfarin (INN) and its salts |
81-81-2 |
201-377-6 |
|
204 |
Ethyl bis(4-hydroxy-2-oxo-1-benzopyran-3-yl)acetate and salts of the acid |
548-00-5 |
208-940-5 |
|
205 |
Methocarbamol (INN) |
532-03-6 |
208-524-3 |
|
206 |
Propatylnitrate (INN) |
2921-92-8 |
220-866-5 |
|
207 |
4,4'-Dihydroxy-3,3'-(3-methylthiopropylidene) dicoumarin |
|
|
|
208 |
Fenadiazole (INN) |
1008-65-7 |
|
|
209 |
Nitroxoline (INN) and its salts |
4008-48-4 |
223-662-4 |
|
210 |
Hyoscyamine, its salts and derivatives |
101-31-5 |
202-933-0 |
|
211 |
Hyoscyamus niger L. (leaves, seeds, powder and galenical preparations) |
84603-65-6 |
283-265-7 |
|
212 |
Pemoline (INN) and its salts |
2152-34-3 |
218-438-8 |
|
213 |
Iodine |
7553-56-2 |
231-442-4 |
|
214 |
Decamethylenebis(trimethylammonium) salts, e. g. decamethonium bromide (INN) |
541-22-0 |
208-772-2 |
|
215 |
Ipecacuanha (Cephaelis ipecacuanha Brot. and related species) (roots, powder and galenical preparations) |
8012-96-2 |
232-385-8 |
|
216 |
(2-Isopropylpent4-enoyl)urea (apronalide) |
528-92-7 |
208-443-3 |
|
217 |
α-Santonin [(3S,5aR,9bS)-3,3a,4,5,5a,9b-hexahydro-3,5a,9-trimethylnaphto [1,2-b] furan-2,8-dione] |
481-06-1 |
207-560-7 |
|
218 |
Lobelia inflata L. and its galenical preparations |
84696-23-1 |
283-642-6 |
|
219 |
Lobeline (INN) and its salts |
90-69-7 |
202-012-3 |
|
220 |
Barbiturates |
|
|
|
221 |
Mercury and its compounds, except those special cases included in Annex V |
7439-97-6 |
231-106-7 |
|
222 |
3,4,5-Trimethoxyphenethylamine (Mescaline) and its salts |
54-04-6 |
200-190-7 |
|
223 |
Metaldehyde |
9002-91-9 |
|
|
224 |
2-(4-Allyl-2-methoxyphenoxy)-N,N-diethylacetamide and its salts |
305-13-5 |
|
|
225 |
Coumetarol (INN) |
4366-18-1 |
224-455-1 |
|
226 |
Dextromethorphan (INN) and its salts |
125-71-3 |
204-752-2 |
|
227 |
2-Methylheptylamine and its salts |
540-43-2 |
|
|
228 |
Isometheptene (INN) and its salts |
503-01-5 |
207-959-6 |
|
229 |
Mecamylamine (INN) |
60-40-2 |
200-476-1 |
|
230 |
Guaifenesin (INN) |
93-14-1 |
202-222-5 |
|
231 |
Dicoumarol (INN) |
66-76-2 |
200-632-9 |
|
232 |
Phenmetrazine (INN), its derivatives and salts |
134-49-6 |
205-143-4 |
|
233 |
Thiamazole (INN) |
60-56-0 |
200-482-4 |
|
234 |
3,4-Dihydro-2-methoxy-2-methyl-4-phenyl-2H,5H-pyrano [3,2-c]-[1] benzopyran-5-one (cyclocoumarol) |
518-20-7 |
208-248-3 |
|
235 |
Carisoprodol (INN) |
78-44-4 |
201-118-7 |
|
236 |
Meprobamate (INN) |
57-53-4 |
200-337-5 |
|
237 |
Tefazoline (INN) and its salts |
1082-56-0 |
|
|
238 |
Arecoline |
63-75-2 |
200-565-5 |
|
239 |
Poldine metilsulfate (INN) |
545-80-2 |
208-894-6 |
|
240 |
Hydroxyzine (INN) |
68-88-2 |
200-693-1 |
|
241 |
2-Naphthol |
135-19-3 |
205-182-7 |
|
242 |
1-and 2-Naphthylamines and their salts |
134-32-7/91-59-8 |
205-138-7/202-080-4 |
|
243 |
3-(1-Naphthyl)-4-hydroxycoumarin |
39923-41-6 |
|
|
244 |
Naphazoline (INN) and its salts |
835-31-4 |
212-641-5 |
|
245 |
Neostigmine and its salts e. g. neostigmine bromide (INN) |
114-80-7 |
204-054-8 |
|
246 |
Nicotine and its salts |
54-11-5 |
200-193-3 |
|
247 |
Amyl nitrites |
110-46-3 |
203-770-8 |
|
248 |
Inorganic nitrites, with the exception of sodium nitrite |
14797-65-0 |
|
|
249 |
Nitrobenzene |
98-95-3 |
202-716-0 |
|
250 |
Nitrocresols and their alkali metal salts |
12167-20-3 |
|
|
251 |
Nitrofurantoin (INN) |
67-20-9 |
200-646-5 |
|
252 |
Furazolidone (INN) |
67-45-8 |
200-653-3 |
|
253 |
Nitroglycerin; Propane-1,2,3-triyl trinitrate |
55-63-0 |
200-240-8 |
|
254 |
Acenocoumarol (INN) |
152-72-7 |
205-807-3 |
|
255 |
Alkali pentacyanonitrosylferrate (2-) e.g. |
14402-89-2/13755-38-9 |
238-373-9 / - |
|
256 |
Nitrostilbenes, their homologues and their derivatives |
|
|
|
257 |
Noradrenaline and its salts |
51-41-2 |
200-096-6 |
|
258 |
Noscapine (INN) and its salts |
128-62-1 |
204-899-2 |
|
259 |
Guanethidine (INN) and its salts |
55-65-2 |
200-241-3 |
|
260 |
Oestrogens |
|
|
|
261 |
Oleandrin |
465-16-7 |
207-361-5 |
|
262 |
Chlortalidone (INN) |
77-36-1 |
201-022-5 |
|
263 |
Pelletierine and its salts |
2858-66-4/4396-01-4 |
220-673-6/224-523-0 |
|
264 |
Pentachloroethane |
76-01-7 |
200-925-1 |
|
265 |
Pentaerithrityl tetranitrate (INN) |
78-11-5 |
201-084-3 |
|
266 |
Petrichloral (INN) |
78-12-6 |
|
|
267 |
Octamylamine (INN) and its salts |
502-59-0 |
207-947-0 |
|
268 |
Picric acid |
88-89-1 |
201-865-9 |
|
269 |
Phenacemide (INN) |
63-98-9 |
200-570-2 |
|
270 |
Difencloxazine (INN) |
5617-26-5 |
|
|
271 |
2-Phenylindan-1,3-dione (phenindione (INN)) |
83-12-5 |
201-454-4 |
|
272 |
Ethylphenacemide (pheneturide (INN)) |
90-49-3 |
201-998-2 |
|
273 |
Phenprocoumon (INN) |
435-97-2 |
207-108-9 |
|
274 |
Fenyramidol (INN) |
553-69-5 |
209-044-7 |
|
275 |
Triamterene (INN) and its salts |
396-01-0 |
206-904-3 |
|
276 |
Tetraethyl pyrophosphate (TEPP - ISO) |
107-49-3 |
203-495-3 |
|
277 |
Tritolyl phosphate |
1330-78-5 |
215-548-8 |
|
278 |
Psilocybine (INN) |
520-52-5 |
208-294-4 |
|
279 |
Phosphorus and metal phosphides |
7723-14-0 |
231-768-7 |
|
280 |
Thalidomide (INN) and its salts |
50-35-1 |
200-031-1 |
|
281 |
Physostigma venenosum Balf. |
89958-15-6 |
289-638-0 |
|
282 |
Picrotoxin |
124-87-8 |
204-716-6 |
|
283 |
Pilocarpine and its salts |
92-13-7 |
202-128-4 |
|
284 |
α-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its salts |
24558-01-8 |
|
|
285 |
Pipradrol (INN) and its salts |
467-60-7 |
207-394-5 |
|
286 |
Azacyclonol (INN) and its salts |
115-46-8 |
204-092-5 |
|
287 |
Bietamiverine (INN) |
479-81-2 |
207-538-7 |
|
288 |
Butopiprine (INN) and its salts |
55837-15-5 |
259-848-7 |
|
289 |
Lead and its compounds |
7439-92-1 |
231-100-4 |
|
290 |
Coniine |
458-88-8 |
207-282-6 |
|
291 |
Prunus laurocerasus L. (‘cherry laurel water’) |
89997-54-6 |
289-689-9 |
|
292 |
Metyrapone (INN) |
54-36-4 |
200-206-2 |
|
293 |
Radioactive substances, as defined by Directive 96/29/Euratom (1) laying down basic safety standards for the protection of the health of workers and the general public against the dangers arising from ionising radiation |
|
|
|
294 |
Juniperus sabina L. (leaves, essential oil and galenical preparations) |
90046-04-1 |
289-971-1 |
|
295 |
Hyoscine, its salts and derivatives |
51-34-3 |
200-090-3 |
|
296 |
Gold salts |
|
|
|
297 |
Selenium and its compounds with the exception of selenium disulphide under the conditions set out under reference No 49 in Annex III |
7782-49-2 |
231-957-4 |
|
298 |
Solanum nigrum L. and its galenical preparations |
84929-77-1 |
284-555-6 |
|
299 |
Sparteine (INN) and its salts |
90-39-1 |
201-988-8 |
|
300 |
Glucocorticoids (Corticosteroids) |
|
|
|
301 |
Datura stramonium L. and its galenical preparations |
84696-08-2 |
283-627-4 |
|
302 |
Strophantines, their aglucones and their respective derivatives |
11005-63-3 |
234-239-9 |
|
303 |
Strophantus species and their galenical preparations |
|
|
|
304 |
Strychnine and its salts |
57-24-9 |
200-319-7 |
|
305 |
Strychnos species and their galenical preparations |
|
|
|
306 |
Narcotics, natural and synthetic: All substances listed in Tables I and II of the single Convention on narcotic drugs signed in New York on 30 March 1961 |
|
|
|
307 |
Sulphonamides (sulphanilamide and its derivatives obtained by substitution of one or more H-atoms of the -NH2 groups) and their salts |
|
|
|
308 |
Sultiame (INN) |
61-56-3 |
200-511-0 |
|
309 |
Neodymium and its salts |
7440-00-8 |
231-109-3 |
|
310 |
Thiotepa (INN) |
52-24-4 |
200-135-7 |
|
311 |
Pilocarpus jaborandi Holmes and its galenical preparations |
84696-42-4 |
283-649-4 |
|
312 |
Tellurium and its compounds |
13494-80-9 |
236-813-4 |
|
313 |
Xylometazoline (INN) and its salts |
526-36-3 |
208-390-6 |
|
314 |
Tetrachloroethylene |
127-18-4 |
204-825-9 |
|
315 |
Carbon tetrachloride |
56-23-5 |
200-262-8 |
|
316 |
Hexaethyl tetraphosphate |
757-58-4 |
212-057-0 |
|
317 |
Thallium and its compounds |
7440-28-0 |
231-138-1 |
|
318 |
Thevetia neriifolia Juss., glycoside extract |
90147-54-9 |
290-446-4 |
|
319 |
Ethionamide (INN) |
536-33-4 |
208-628-9 |
|
320 |
Phenothiazine (INN) and its compounds |
92-84-2 |
202-196-5 |
|
321 |
Thiourea and its derivatives, with the exception of the one listed in Annex III |
62-56-6 |
200-543-5 |
|
322 |
Mephenesin (INN) and its esters |
59-47-2 |
200-427-4 |
|
323 |
Vaccines, toxins or serums defined as immunological medicinal products pursuant to Article 1(4) of Directive 2001/83/EC |
|
|
|
324 |
Tranylcypromine (INN) and its salts |
155-09-9 |
205-841-9 |
|
325 |
Trichloronitromethane (chloropicrine) |
76-06-2 |
200-930-9 |
|
326 |
2,2,2-Tribromoethanol (tribromoethyl alcohol) |
75-80-9 |
200-903-1 |
|
327 |
Trichlormethine (INN) and its salts |
817-09-4 |
212-442-3 |
|
328 |
Tretamine (INN) |
51-18-3 |
200-083-5 |
|
329 |
Gallamine triethiodide (INN) |
65-29-2 |
200-605-1 |
|
330 |
Urginea scilla Steinh. and its galenical preparations |
84650-62-4 |
283-520-2 |
|
331 |
Veratrine, its salts and galenical preparations |
8051-02-3 |
613-062-00-4 |
|
332 |
Schoenocaulon officinale Lind (seeds and galenical preparations) |
84604-18-2 |
283-296-6 |
|
333 |
Veratrum spp. and their preparations |
90131-91-2 |
290-407-1 |
|
334 |
Vinyl chloride monomer |
75-01-4 |
200-831-0 |
|
335 |
Ergocalciferol (INN) and cholecalciferol (vitamins D2 and D3) |
50-14-6/67-97-0 |
200-014-9/200-673-2 |
|
336 |
Salts of O-alkyldithiocarbonic acids (xanthates) |
|
|
|
337 |
Yohimbine and its salts |
146-48-5 |
205-672-0 |
|
338 |
Dimethyl sulfoxide (INN) |
67-68-5 |
200-664-3 |
|
339 |
Diphenhydramine (INN) and its salts |
58-73-1 |
200-396-7 |
|
340 |
4-tert-Butylphenol |
98-54-4 |
202-679-0 |
|
341 |
4-tert-Butylpyrocatechol |
98-29-3 |
202-653-9 |
|
342 |
Dihydrotachysterol (INN) |
67-96-9 |
200-672-7 |
|
343 |
Dioxane |
123-91-1 |
204-661-8 |
|
344 |
Morpholine and its salts |
110-91-8 |
203-815-1 |
|
345. |
Pyrethrum album L. and its galenical preparations |
|
|
|
346 |
2-[4-Methoxybenzyl-N-(2-pyridyl)amino]ethyldimethylamine maleate (Mepyramine maleate; pyrilamine maleate) |
59-33-6 |
200-422-7 |
|
347 |
Tripelennamine (INN) |
91-81-6 |
202-100-1 |
|
348 |
Tetrachlorosalicylanilides |
7426-07-5 |
|
|
349 |
Dichlorosalicylanilides |
1147-98-4 |
|
|
350 |
Tetrabromosalicylanilides |
|
|
|
351 |
Dibromosalicylanilides |
|
|
|
352 |
Bithionol (INN) |
97-18-7 |
202-565-0 |
|
353 |
Thiuram monosulphides |
97-74-5 |
202-605-7 |
|
354 |
Moved or deleted |
|
|
|
355 |
Dimethylformamide (N,N-Dimethylformamide) |
68-12-2 |
200-679-5 |
|
356 |
4-Phenylbut-3-en-2-one (Benzylidene acetone) |
122-57-6 |
204-555-1 |
|
357 |
Benzoates of 4-hydroxy-3-methoxycinnamyl alcohol (coniferyl alcohol) except for normal content in natural essences used |
|
|
|
358 |
Furocoumarines (e. g. trioxysalen (INN), 8-methoxypsoralen, 5-methoxypsoralen) except for normal content in natural essences used. In sun protection and in bronzing products, furocoumarines shall be below 1 mg/kg |
3902-71-4/298-81-7/484-20-8 |
223-459-0/206-066-9/207-604-5 |
|
359 |
Oil from the seeds of Laurus nobilis L. |
84603-73-6 |
283-272-5 |
|
360 |
Safrole except for normal content in the natural essences used and provided the concentration does not exceed: 100 ppm in the finished product, 50 ppm in products for dental and oral hygiene, and provided that Safrole is not present in toothpastes intended specifically for children |
94-59-7 |
202-345-4 |
|
361 |
5,5'-Di-isopropyl-2,2'-dimethylbiphenyl-4,4'-diyl dihypoiodite (thymol iodide) |
552-22-7 |
209-007-5 |
|
362 |
3'-Ethyl-5',6',7',8'-tetrahydro-5',5',8',8'-tetramethyl-2'-acetonaphthone or 7-acetyl-6-ethyl-1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphtalen (AETT; Versalide) |
88-29-9 |
201-817-7 |
|
363 |
o-Phenylenediamine and its salts |
95-54-5 |
202-430-6 |
|
364 |
4-Methyl-m-phenylenediamine (Toluene-2,4-diamine) and its salts |
95-80-7 |
202-453-1 |
|
365 |
Aristolochic acid and its salts; Aristolochia spp. and their preparations |
475-80-9/313-67-7/15918-62-4 |
202-499-6/206-238-3/- |
|
366 |
Chloroform |
67-66-3 |
200-663-8 |
|
367 |
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) |
1746-01-6 |
217-122-7 |
|
368 |
2,6-Dimethyl-1,3-dioxan-4-yl acetate (Dimethoxane) |
828-00-2 |
212-579-9 |
|
369 |
Pyrithione sodium (INNM) (2) |
3811-73-2 |
223-296-5 |
|
370 |
N-(Trichloromethylthio)-4-cyclohexene-1,2-dicarboximide (Captan - ISO) |
133-06-2 |
205-087-0 |
|
371 |
2,2'-Dihydroxy-3,3',5,5',6,6'-hexachlorodiphenylmethane (Hexachlorophene (INN)) |
70-30-4 |
200-733-8 |
|
372 |
6-(Piperidinyl)-2,4-pyrimidinediamine 3-oxide (Minoxidil (INN)) and its salts |
38304-91-5 |
253-874-2 |
|
373 |
3,4',5-Tribromosalicylanilide (Tribromsalan (INN)) |
87-10-5 |
201-723-6 |
|
374 |
Phytolacca spp. and their preparations |
65497-07-6/60820-94-2 |
|
|
375 |
Tretinoin (INN) (retinoic acid and its salts) |
302-79-4 |
206-129-0 |
|
376 |
1-Methoxy-2,4-diaminobenzene (2,4-diaminoanisole - CI 76050) and its salts |
615-05-4 |
210-406-1 |
|
377 |
1-Methoxy-2,5-diaminobenzene (2,5-diaminoanisole) and its salts |
5307-02-8 |
226-161-9 |
|
378 |
Colouring agent CI 12140 |
3118-97-6 |
221-490-4 |
|
379 |
Colouring agent CI 26105 (Solvent Red 24) |
85-83-6 |
201-635-8 |
|
380 |
Colouring agent CI 42555 (Basic Violet 3) Colouring agent CI 42555:1 Colouring agent CI 42555:2 |
548-62-9 467-63-0 |
208-953-6 207-396-6 |
|
381 |
Amyl 4-dimethylaminobenzoate, mixed isomers (Padimate A (INN)) |
14779-78-3 |
238-849-6 |
|
383 |
2-Amino-4-nitrophenol |
99-57-0 |
202-767-9 |
|
384 |
2-Amino-5-nitrophenol |
121-88-0 |
204-503-8 |
|
385 |
11-α-Hydroxypregn-4-ene-3,20-dione and its esters |
80-75-1 |
201-306-9 |
|
386 |
Colouring agent CI 42640 ([4-[[4-(Dimethylamino)phenyl][4-[ethyl(3-sulphonatobenzyl)amino]phenyl]methylene]cyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulphonatobenzyl)ammonium, sodium salt) |
1694-09-3 |
216-901-9 |
|
387 |
Colouring agent CI 13065 |
587-98-4 |
209-608-2 |
|
388 |
Colouring agent CI 42535 (Basic Violet 1) |
8004-87-3 |
|
|
389 |
Colouring agent CI 61554 (Solvent Blue 35) |
17354-14-2 |
241-379-4 |
|
390 |
Anti-androgens of steroidal structure |
|
|
|
391 |
Zirconium and its compounds, with the exception of the substances listed under reference number 50 in Annex III, and the zirconium lakes, pigments or salts of the colouring agents when listed in Annex IV |
7440-67-7 |
231-176-9 |
|
392 |
Moved or deleted |
|
|
|
393 |
Acetonitrile |
75-05-8 |
200-835-2 |
|
394 |
Tetrahydrozoline (Tetryzoline (INN)) and its salts |
84-22-0 |
201-522-3 |
|
395 |
Hydroxy-8-quinoline and its sulphate bis(8-hydroxyquinolinium) sulphate, except for the uses of the sulphate provided for in entry 51 of Annex III |
148-24-3 134-31-6 |
205-711-1 205-137-1 |
|
396 |
Dithio-2,2-bispyridine-dioxide 1,1' (additive with trihydrated magnesium sulphate) - (pyrithione disulphide + magnesium sulphate) |
43143-11-9 |
256-115-3 |
|
397 |
Colouring agent CI 12075 (Pigment Orange 5) and its lakes, pigments and salts |
3468-63-1 |
222-429-4 |
|
398 |
Colouring agent CI 45170 and CI 45170:1 (Basic Violet 10) |
81-88-9/509-34-2 |
201-383-9/208-096-8 |
|
399 |
Lidocaine (INN) |
137-58-6 |
205-302-8 |
|
400 |
1,2-Epoxybutane |
106-88-7 |
203-438-2 |
|
401 |
Colouring agent CI 15585 |
5160-02-1/2092-56-0 |
225-935-3/218-248-5 |
|
402 |
Strontium lactate |
29870-99-3 |
249-915-9 |
|
403 |
Strontium nitrate |
10042-76-9 |
233-131-9 |
|
404 |
Strontium polycarboxylate |
|
|
|
405 |
Pramocaine (INN) |
140-65-8 |
205-425-7 |
|
406 |
4-Ethoxy-m-phenylenediamine and its salts |
5862-77-1 |
|
|
407 |
2,4-Diaminophenylethanol and its salts |
14572-93-1 |
|
|
408 |
Pyrocatechol (Catechol) |
120-80-9 |
204-427-5 |
|
409 |
Pyrogallol |
87-66-1 |
201-762-9 |
|
410 |
Nitrosamines e.g. Dimethylnitrosoamine; Nitrosodipropylamine; 2,2'-Nitrosoimino)bisethanol |
62-75-9/621-64-7/1116-54-7 |
200-549-8/210-698-0/214-237-4 |
|
411 |
Secondary alkyl- and alkanolamines and their salts |
|
|
|
412 |
4-Amino-2-nitrophenol |
119-34-6 |
204-316-1 |
|
413 |
2-Methyl-m-phenylenediamine (Toluene-2,6-diamine) |
823-40-5 |
212-513-9 |
|
414 |
4-tert.-Butyl-3-methoxy-2,6-dinitrotoluene (Musk Ambrette) |
83-66-9 |
201-493-7 |
|
415 |
Moved or deleted |
|
|
|
416 |
Cells, tissues or products of human origin |
|
|
|
417 |
3,3-Bis(4-hydroxyphenyl)phthalide (Phenolphthalein (INN)) |
77-09-8 |
201-004-7 |
|
418 |
3-Imidazol-4-ylacrylic acid (Urocanic acid) and its ethyl ester |
104-98-3/27538-35-8 |
203-258-4/248-515-1 |
|
419 |
Category 1 material and Category 2 material as defined in Articles 4 and 5 respectively of Regulation (EC) No 1774/2002 of the European Parliament and of the Council (3), and ingredients derived therefrom |
|
|
|
420 |
Crude and refined coal tars |
8007-45-2 |
232-361-7 |
|
421 |
1,1,3,3,5-Pentamethyl-4,6-dinitroindane (Moskene) |
116-66-5 |
204-149-4 |
|
422 |
5-tert.-Butyl-1,2,3-trimethyl-4,6-dinitrobenzene (Musk Tibetene) |
145-39-1 |
205-651-6 |
|
423 |
Alanroot oil (Inula helenium L.), when used as a fragrance ingredient |
97676-35-2 |
|
|
424 |
Benzyl cyanide, when used as a fragrance ingredient |
140-29-4 |
205-410-5 |
|
425 |
Cyclamen alcohol, when used as a fragrance ingredient |
4756-19-8 |
225-289-2 |
|
426 |
Diethyl maleate, when used as a fragrance ingredient |
141-05-9 |
205-451-9 |
|
427 |
3,4-Dihydrocoumarin, when used as a fragrance ingredient |
119-84-6 |
204-354-9 |
|
428 |
2,4-Dihydroxy-3-methylbenzaldehyde, when used as a fragrance ingredient |
6248-20-0 |
228-369-5 |
|
429 |
3,7-Dimethyl-2-octen-1-ol (6,7-Dihydrogeraniol), when used as a fragrance ingredient |
40607-48-5 |
254-999-5 |
|
430 |
4,6-Dimethyl-8-tert-butylcoumarin, when used as a fragrance ingredient |
17874-34-9 |
241-827-9 |
|
431 |
Dimethyl citraconate, when used as a fragrance ingredient |
617-54-9 |
|
|
432 |
7,11-Dimethyl-4,6,10-dodecatrien-3-one (Pseudomethylionone), when used as a fragrance ingredient |
26651-96-7 |
247-878-3 |
|
433 |
6,10-Dimethyl-3,5,9-undecatrien-2-one (Pseudoionone), when used as a fragrance ingredient |
141-10-6 |
205-457-1 |
|
434 |
Diphenylamine, when used as a fragrance ingredient |
122-39-4 |
204-539-4 |
|
435 |
Ethyl acrylate, when used as a fragrance ingredient |
140-88-5 |
205-438-8 |
|
436 |
Fig leaf absolute (Ficus carica L.), when used as a fragrance ingredient |
68916-52-9 |
|
|
437 |
trans-2-Heptenal, when used as a fragrance ingredient |
18829-55-5 |
242-608-0 |
|
438 |
trans-2-Hexenal diethyl acetal, when used as a fragrance ingredient |
67746-30-9 |
266-989-8 |
|
439 |
trans-2-Hexenal dimethyl acetal, when used as a fragrance ingredient |
18318-83-7 |
242-204-4 |
|
440 |
Hydroabietyl alcohol, when used as a fragrance ingredient |
13393-93-6 |
236-476-3 |
|
441 |
6-Isopropyl-2-decahydronaphthalenol, when used as a fragrance ingredient |
34131-99-2 |
251-841-7 |
|
442 |
7-Methoxycoumarin, when used as a fragrance ingredient |
531-59-9 |
208-513-3 |
|
443 |
4-(4-Methoxyphenyl)-3-butene-2-one (Anisylidene acetone), when used as a fragrance ingredient |
943-88-4 |
213-404-9 |
|
444 |
1-(4-Methoxyphenyl)-1-penten-3-one (alpha-Methylanisylideneacetone), when used as a fragrance ingredient |
104-27-8 |
203-190-5 |
|
445 |
Methyl trans-2-butenoate, when used as a fragrance ingredient |
623-43-8 |
210-793-7 |
|
446 |
7-Methylcoumarin, when used as a fragrance ingredient |
2445-83-2 |
219-499-3 |
|
447 |
5-Methyl-2,3-hexanedione (Acetyl isovaleryl), when used as a fragrance ingredient |
13706-86-0 |
237-241-8 |
|
448 |
2-Pentylidenecyclohexanone, when used as a fragrance ingredient |
25677-40-1 |
247-178-8 |
|
449 |
3,6,10-Trimethyl-3,5,9-undecatrien-2-one (Pseudo-Isomethyl ionone), when used as a fragrance ingredient |
1117-41-5 |
214-245-8 |
|
450 |
Verbena essential oils (Lippia citriodora Kunth.) and derivatives other than absolute when used as a fragrance ingredient |
8024-12-2 |
285-515-0 |
|
451 |
Moved or deleted |
|
|
|
452 |
6-(2-Chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane |
37894-46-5 |
253-704-7 |
|
453 |
Cobalt dichloride |
7646-79-9 |
231-589-4 |
|
454 |
Cobalt sulphate |
10124-43-3 |
233-334-2 |
|
455 |
Nickel monoxide |
1313-99-1 |
215-215-7 |
|
456 |
Dinickel trioxide |
1314-06-3 |
215-217-8 |
|
457 |
Nickel dioxide |
12035-36-8 |
234-823-3 |
|
458 |
Trinickel disulphide |
12035-72-2 |
234-829-6 |
|
459 |
Tetracarbonylnickel |
13463-39-3 |
236-669-2 |
|
460 |
Nickel sulphide |
16812-54-7 |
240-841-2 |
|
461 |
Potassium bromate |
7758-01-2 |
231-829-8 |
|
462 |
Carbon monoxide |
630-08-0 |
211-128-3 |
|
463 |
Buta-1,3-diene, see also entries 464-611 |
106-99-0 |
203-450-8 |
|
464 |
Isobutane, if it contains ≥ 0,1 % w/w Butadiene |
75-28-5 |
200-857-2 |
|
465 |
Butane, if it contains ≥ 0,1 % w/w Butadiene |
106-97-8 |
203-448-7 |
|
466 |
Gases (petroleum), C3-4, if they contain > 0,1 % w/w Butadiene |
68131-75-9 |
268-629-5 |
|
467 |
Tail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber, if it contains > 0,1 % w/w Butadiene |
68307-98-2 |
269-617-2 |
|
468 |
Tail gas (petroleum), catalytic polymn. naphtha fractionation stabiliser, if it contains > 0,1 % w/w Butadiene |
68307-99-3 |
269-618-8 |
|
469 |
Tail gas (petroleum), catalytic reformed naphtha fractionation stabiliser, hydrogen sulfide-free, if it contains > 0,1 % w/w Butadiene |
68308-00-9 |
269-619-3 |
|
470 |
Tail gas (petroleum), cracked distillate hydrotreater stripper, if it contains > 0,1 % w/w Butadiene |
68308-01-0 |
269-620-9 |
|
471 |
Tail gas (petroleum), gas oil catalytic cracking absorber, if it contains > 0,1 % w/w Butadiene |
68308-03-2 |
269-623-5 |
|
472 |
Tail gas (petroleum), gas recovery plant, if it contains > 0,1 % w/w Butadiene |
68308-04-3 |
269-624-0 |
|
473 |
Tail gas (petroleum), gas recovery plant deethaniser, if it contains > 0,1 % w/w Butadiene |
68308-05-4 |
269-625-6 |
|
474 |
Tail gas (petroleum), hydrodesulfurised distillate and hydrodesulfurised naphtha fractionator, acid-free, if it contains > 0,1 % w/w Butadiene |
68308-06-5 |
269-626-1 |
|
475 |
Tail gas (petroleum), hydrodesulfurised vacuum gas oil stripper, hydrogen sulfide-free, if it contains > 0,1 % w/w Butadiene |
68308-07-6 |
269-627-7 |
|
476 |
Tail gas (petroleum), isomerised naphtha fractionation stabiliser, if it contains > 0,1 % w/w Butadiene |
68308-08-7 |
269-628-2 |
|
477 |
Tail gas (petroleum), light straight-run naphtha stabiliser, hydrogen sulfide-free, if it contains > 0,1 % w/w Butadiene |
68308-09-8 |
269-629-8 |
|
478 |
Tail gas (petroleum), straight-run distillate hydrodesulfurised, hydrogen sulfide-free, if it contains > 0,1 % w/w Butadiene |
68308-10-1 |
269-630-3 |
|
479 |
Tail gas (petroleum), propane-propylene alkylation feed prep deethaniser, if it contains > 0,1 % w/w Butadiene |
68308-11-2 |
269-631-9 |
|
480 |
Tail gas (petroleum), vacuum gas oil hydrodesulfurised, hydrogen sulfide-free, if it contains > 0,1 % w/w Butadiene |
68308-12-3 |
269-632-4 |
|
481 |
Gases (petroleum), catalytic cracked overheads, if they contain > 0,1 % w/w Butadiene |
68409-99-4 |
270-071-2 |
|
482 |
Alkanes, C1-2, if they contain > 0,1 % w/w Butadiene |
68475-57-0 |
270-651-5 |
|
483 |
Alkanes, C2-3, if they contain > 0,1 % w/w Butadiene |
68475-58-1 |
270-652-0 |
|
484 |
Alkanes, C3-4, if they contain > 0,1 % w/w Butadiene |
68475-59-2 |
270-653-6 |
|
485 |
Alkanes, C4-5, if they contain > 0,1 % w/w Butadiene |
68475-60-5 |
270-654-1 |
|
486 |
Fuel-gases, if they contain > 0,1 % w/w Butadiene |
68476-26-6 |
270-667-2 |
|
487 |
Fuel gases, crude oil distillates, if they contain > 0,1 % w/w Butadiene |
68476-29-9 |
270-670-9 |
|
488 |
Hydrocarbons, C3-4, if they contain > 0,1 % w/w Butadiene |
68476-40-4 |
270-681-9 |
|
489 |
Hydrocarbons, C4-5, if they contain > 0,1 % w/w Butadiene |
68476-42-6 |
270-682-4 |
|
490 |
Hydrocarbons, C2-4, C3-rich, if they contain > 0,1 % w/w Butadiene |
68476-49-3 |
270-689-2 |
|
491 |
Petroleum gases, liquefied, if they contain > 0,1 % w/w Butadiene |
68476-85-7 |
270-704-2 |
|
492 |
Petroleum gases, liquefied, sweetened, if they contain > 0,1 % w/w Butadiene |
68476-86-8 |
270-705-8 |
|
493 |
Gases (petroleum), C3-4, isobutane-rich if they contain > 0,1 % w/w Butadiene |
68477-33-8 |
270-724-1 |
|
494 |
Distillates (petroleum), C3-6, piperylene-rich, if they contain > 0,1 % w/w Butadiene |
68477-35-0 |
270-726-2 |
|
495 |
Gases (petroleum), amine system feed, if they contain > 0,1 % w/w Butadiene |
68477-65-6 |
270-746-1 |
|
496 |
Gases (petroleum), benzene unit hydrodesulfurised off, if they contain > 0,1 % w/w Butadiene |
68477-66-7 |
270-747-7 |
|
497 |
Gases (petroleum), benzene unit recycle, hydrogen-rich, if they contain > 0,1 % w/w Butadiene |
68477-67-8 |
270-748-2 |
|
498 |
Gases (petroleum), blend oil, hydrogen-nitrogen-rich, if they contain > 0,1 % w/w Butadiene |
68477-68-9 |
270-749-8 |
|
499 |
Gases (petroleum), butane splitter overheads, if they contain > 0,1 % w/w Butadiene |
68477-69-0 |
270-750-3 |
|
500 |
Gases (petroleum), C2-3, if they contain > 0,1 % w/w Butadiene |
68477-70-3 |
270-751-9 |
|
501 |
Gases (petroleum), catalytic-cracked gas oil depropaniser bottoms, C4-rich acid-free, if they contain > 0,1 % w/w Butadiene |
68477-71-4 |
270-752-4 |
|
502 |
Gases (petroleum), catalytic-cracked naphtha debutaniser bottoms, C3-5-rich, if they contain > 0,1 % w/w Butadiene |
68477-72-5 |
270-754-5 |
|
503 |
Gases (petroleum), catalytic cracked naphtha depropaniser overhead, C3-rich acid-free, if they contain > 0,1 % w/w Butadiene |
68477-73-6 |
270-755-0 |
|
504 |
Gases (petroleum), catalytic cracker, if they contain > 0,1 % w/w Butadiene |
68477-74-7 |
270-756-6 |
|
505 |
Gases (petroleum), catalytic cracker, C1-5-rich, if they contain > 0,1 % w/w Butadiene |
68477-75-8 |
270-757-1 |
|
506 |
Gases (petroleum), catalytic polymd. naphtha stabiliser overhead, C2-4-rich, if they contain > 0,1 % w/w Butadiene |
68477-76-9 |
270-758-7 |
|
507 |
Gases (petroleum), catalytic reformed naphtha stripper overheads, if they contain > 0,1 % w/w Butadiene |
68477-77-0 |
270-759-2 |
|
508 |
Gases (petroleum), catalytic reformer, C1-4-rich, if they contain > 0,1 % w/w Butadiene |
68477-79-2 |
270-760-8 |
|
509 |
Gases (petroleum), C6-8 catalytic reformer recycle, if they contain > 0,1 % w/w Butadiene |
68477-80-5 |
270-761-3 |
|
510 |
Gases (petroleum), C6-8 catalytic reformer, if they contain > 0,1 % w/w Butadiene |
68477-81-6 |
270-762-9 |
|
511 |
Gases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich, if they contain > 0,1 % w/w Butadiene |
68477-82-7 |
270-763-4 |
|
512 |
Gases (petroleum), C3-5 olefinic-paraffinic alkylation feed, if they contain > 0,1 % w/w Butadiene |
68477-83-8 |
270-765-5 |
|
513 |
Gases (petroleum), C2-return stream, if they contain > 0,1 % w/w Butadiene |
68477-84-9 |
270-766-0 |
|
514 |
Gases (petroleum), C4-rich, if they contain > 0,1 % w/w Butadiene |
68477-85-0 |
270-767-6 |
|
515 |
Gases (petroleum), deethaniser overheads, if they contain > 0,1 % w/w Butadiene |
68477-86-1 |
270-768-1 |
|
516 |
Gases (petroleum), deisobutaniser tower overheads, if they contain > 0,1 % w/w Butadiene |
68477-87-2 |
270-769-7 |
|
517 |
Gases (petroleum), depropaniser dry, propene-rich, if they contain > 0,1 % w/w Butadiene |
68477-90-7 |
270-772-3 |
|
518 |
Gases (petroleum), depropaniser overheads, if they contain > 0,1 % w/w Butadiene |
68477-91-8 |
270-773-9 |
|
519 |
Gases (petroleum), dry sour, gas-concn. -unit-off, if they contain > 0,1 % w/w Butadiene |
68477-92-9 |
270-774-4 |
|
520 |
Gases (petroleum), gas concn. reabsorber distn., if they contain > 0,1 % w/w Butadiene |
68477-93-0 |
270-776-5 |
|
521 |
Gases (petroleum), gas recovery plant depropaniser overheads, if they contain > 0,1 % w/w Butadiene |
68477-94-1 |
270-777-0 |
|
522 |
Gases (petroleum), Girbatol unit feed, if they contain > 0,1 % w/w Butadiene |
68477-95-2 |
270-778-6 |
|
523 |
Gases (petroleum), hydrogen absorber off, if they contain > 0,1 % w/w Butadiene |
68477-96-3 |
270-779-1 |
|
524 |
Gases (petroleum), hydrogen-rich, if they contain > 0,1 % w/w Butadiene |
68477-97-4 |
270-780-7 |
|
525 |
Gases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich, if they contain > 0,1 % w/w Butadiene |
68477-98-5 |
270-781-2 |
|
526 |
Gases (petroleum), isomerised naphtha fractionator, C4-rich, hydrogen sulfide-free, if they contain > 0,1 % w/w Butadiene |
68477-99-6 |
270-782-8 |
|
527 |
Gases (petroleum), recycle, hydrogen-rich, if they contain > 0,1 % w/w Butadiene |
68478-00-2 |
270-783-3 |
|
528 |
Gases (petroleum), reformer make-up, hydrogen-rich, if they contain > 0,1 % w/w Butadiene |
68478-01-3 |
270-784-9 |
|
529 |
Gases (petroleum), reforming hydrotreater, if they contain > 0,1 % w/w Butadiene |
68478-02-4 |
270-785-4 |
|
530 |
Gases (petroleum), reforming hydrotreater, hydrogen-methane-rich, if they contain > 0,1 % w/w Butadiene |
68478-03-5 |
270-787-5 |
|
531 |
Gases (petroleum), reforming hydrotreater make-up, hydrogen-rich, if they contain > 0,1 % w/w Butadiene |
68478-04-6 |
270-788-0 |
|
532 |
Gases (petroleum), thermal cracking distn., if they contain > 0,1 % w/w Butadiene |
68478-05-7 |
270-789-6 |
|
533 |
Tail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum, if it contains > 0,1 % w/w Butadiene |
68478-21-7 |
270-802-5 |
|
534 |
Tail gas (petroleum), catalytic cracked naphtha stabilisation absorber, if it contains > 0,1 % w/w Butadiene |
68478-22-8 |
270-803-0 |
|
535 |
Tail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurised combined fractionater, if it contains > 0,1 % w/w Butadiene |
68478-24-0 |
270-804-6 |
|
536 |
Tail gas (petroleum), catalytic cracker refractionation absorber, if it contains > 0,1 % w/w Butadiene |
68478-25-1 |
270-805-1 |
|
537 |
Tail gas (petroleum), catalytic reformed naphtha fractionation stabiliser, if it contains > 0,1 % w/w Butadiene |
68478-26-2 |
270-806-7 |
|
538 |
Tail gas (petroleum), catalytic reformed naphtha separator, if it contains > 0,1 % w/w Butadiene |
68478-27-3 |
270-807-2 |
|
539 |
Tail gas (petroleum), catalytic reformed naphtha stabiliser, if it contains > 0,1 % w/w Butadiene |
68478-28-4 |
270-808-8 |
|
540 |
Tail gas (petroleum), cracked distillate hydrotreater separator, if it contains > 0,1 % w/w Butadiene |
68478-29-5 |
270-809-3 |
|
541 |
Tail gas (petroleum), hydrodesulfurised straight-run naphtha separator, if it contains > 0,1 % w/w Butadiene |
68478-30-8 |
270-810-9 |
|
542 |
Tail gas (petroleum), saturate gas plant mixed stream, C4-rich, if it contains > 0,1 % w/w Butadiene |
68478-32-0 |
270-813-5 |
|
543 |
Tail gas (petroleum), saturate gas recovery plant, C1-2-rich, if it contains > 0,1 % w/w Butadiene |
68478-33-1 |
270-814-0 |
|
544 |
Tail gas (petroleum), vacuum residues thermal cracker, if it contains > 0,1 % w/w Butadiene |
68478-34-2 |
270-815-6 |
|
545 |
Hydrocarbons, C3-4-rich, petroleum distillate, if they contain > 0,1 % w/w Butadiene |
68512-91-4 |
270-990-9 |
|
546 |
Gases (petroleum), catalytic reformed straight-run naphtha stabiliser overheads, if they contain > 0,1 % w/w Butadiene |
68513-14-4 |
270-999-8 |
|
547 |
Gases (petroleum), full-range straight-run naphtha dehexaniser off, if they contain > 0,1 % w/w Butadiene |
68513-15-5 |
271-000-8 |
|
548 |
Gases (petroleum), hydrocracking depropaniser off, hydrocarbon-rich, if they contain > 0,1 % w/w Butadiene |
68513-16-6 |
271-001-3 |
|
549 |
Gases (petroleum), light straight-run naphtha stabiliser off, if they contain > 0,1 % w/w Butadiene |
68513-17-7 |
271-002-9 |
|
550 |
Gases (petroleum), reformer effluent high-pressure flash drum off, if they contain > 0,1 % w/w Butadiene |
68513-18-8 |
271-003-4 |
|
551 |
Gases (petroleum), reformer effluent low-pressure flash drum off, if they contain > 0,1 % w/w Butadiene |
68513-19-9 |
271-005-5 |
|
552 |
Residues (petroleum), alkylation splitter, C4-rich, if they contain > 0,1 % w/w Butadiene |
68513-66-6 |
271-010-2 |
|
553 |
Hydrocarbons, C1-4, if they contain > 0,1 % w/w Butadiene |
68514-31-8 |
271-032-2 |
|
554 |
Hydrocarbons, C1-4, sweetened, if they contain > 0,1 % w/w Butadiene |
68514-36-3 |
271-038-5 |
|
555 |
Gases (petroleum), oil refinery gas distn. off, if they contain > 0,1 % w/w Butadiene |
68527-15-1 |
271-258-1 |
|
556 |
Hydrocarbons, C1-3, if they contain > 0,1 % w/w Butadiene |
68527-16-2 |
271-259-7 |
|
557 |
Hydrocarbons, C1-4, debutaniser fraction, if they contain > 0,1 % w/w Butadiene |
68527-19-5 |
271-261-8 |
|
558 |
Gases (petroleum), benzene unit hydrotreater depentaniser overheads, if they contain > 0,1 % w/w Butadiene |
68602-82-4 |
271-623-5 |
|
559 |
Gases (petroleum), C1-5, wet, if they contain > 0,1 % w/w Butadiene |
68602-83-5 |
271-624-0 |
|
560 |
Gases (petroleum), secondary absorber off, fluidised catalytic cracker overheads fractionator, if they contain > 0,1 % w/w Butadiene |
68602-84-6 |
271-625-6 |
|
561 |
Hydrocarbons, C2-4, if they contain > 0,1 % w/w Butadiene |
68606-25-7 |
271-734-9 |
|
562 |
Hydrocarbons, C3, if they contain > 0,1 % w/w Butadiene |
68606-26-8 |
271-735-4 |
|
563 |
Gases (petroleum), alkylation feed, if they contain > 0,1 % w/w Butadiene |
68606-27-9 |
271-737-5 |
|
564 |
Gases (petroleum), depropaniser bottoms fractionation off, if they contain > 0,1 % w/w Butadiene |
68606-34-8 |
271-742-2 |
|
565 |
Petroleum products, refinery gases, if they contain > 0,1 % w/w Butadiene |
68607-11-4 |
271-750-6 |
|
566 |
Gases (petroleum), hydrocracking low-pressure separator, if they contain > 0,1 % w/w Butadiene |
68783-06-2 |
272-182-1 |
|
567 |
Gases (petroleum), refinery blend, if they contain > 0,1 % w/w Butadiene |
68783-07-3 |
272-183-7 |
|
568 |
Gases (petroleum), catalytic cracking, if they contain > 0,1 % w/w Butadiene |
68783-64-2 |
272-203-4 |
|
569 |
Gases (petroleum), C2-4, sweetened, if they contain > 0,1 % w/w Butadiene |
68783-65-3 |
272-205-5 |
|
570 |
Gases (petroleum), refinery, if they contain > 0,1 % w/w Butadiene |
68814-67-5 |
272-338-9 |
|
571 |
Gases (petroleum), platformer products separator off, if they contain > 0,1 % w/w Butadiene |
68814-90-4 |
272-343-6 |
|
572 |
Gases (petroleum), hydrotreated sour kerosine depentaniser stabiliser off, if they contain > 0,1 % w/w Butadiene |
68911-58-0 |
272-775-5 |
|
573 |
Gases (petroleum), hydrotreated sour kerosine flash drum, if they contain > 0,1 % w/w Butadiene |
68911-59-1 |
272-776-0 |
|
574 |
Gases (petroleum), crude oil fractionation off, if they contain > 0,1 % w/w Butadiene |
68918-99-0 |
272-871-7 |
|
575 |
Gases (petroleum), dehexaniser off, if they contain > 0,1 % w/w Butadiene |
68919-00-6 |
272-872-2 |
|
576 |
Gases (petroleum), distillate unifiner desulfurisation stripper off, if they contain > 0,1 % w/w Butadiene |
68919-01-7 |
272-873-8 |
|
577 |
Gases (petroleum), fluidised catalytic cracker fractionation off if they contain > 0,1 % w/w Butadiene |
68919-02-8 |
272-874-3 |
|
578 |
Gases (petroleum), fluidised catalytic cracker scrubbing secondary absorber off, if they contain > 0,1 % w/w Butadiene |
68919-03-9 |
272-875-9 |
|
579 |
Gases (petroleum), heavy distillate hydrotreater desulfurisation stripper off, if they contain > 0,1 % w/w Butadiene |
68919-04-0 |
272-876-4 |
|
580 |
Gases (petroleum), light straight run gasoline fractionation stabiliser off, if they contain > 0,1 % w/w Butadiene |
68919-05-1 |
272-878-5 |
|
581 |
Gases (petroleum), naphtha unifiner desulfurisation stripper off, if they contain > 0,1 % w/w Butadiene |
68919-06-2 |
272-879-0 |
|
582 |
Gases (petroleum), platformer stabiliser off, light ends fractionation, if they contain > 0,1 % w/w Butadiene |
68919-07-3 |
272-880-6 |
|
583 |
Gases (petroleum), preflash tower off, crude distn., if they contain > 0,1 % w/w Butadiene |
68919-08-4 |
272-881-1 |
|
584 |
Gases (petroleum), straight-run naphtha catalytic reforming off, if they contain > 0,1 % w/w Butadiene |
68919-09-5 |
272-882-7 |
|
585 |
Gases (petroleum), straight-run stabiliser off, if they contain > 0,1 % w/w Butadiene |
68919-10-8 |
272-883-2 |
|
586 |
Gases (petroleum), tar stripper off, if they contain > 0,1 % w/w Butadiene |
68919-11-9 |
272-884-8 |
|
587 |
Gases (petroleum), unifiner stripper off, if they contain > 0,1 % w/w Butadiene |
68919-12-0 |
272-885-3 |
|
588 |
Gases (petroleum), fluidised catalytic cracker splitter overheads, if they contain > 0,1 % w/w Butadiene |
68919-20-0 |
272-893-7 |
|
589 |
Gases (petroleum), catalytic cracked naphtha debutaniser, if they contain > 0,1 % w/w Butadiene |
68952-76-1 |
273-169-3 |
|
590 |
Tail gas (petroleum), catalytic cracked distillate and naphtha stabiliser, if it contains > 0,1 % w/w Butadiene |
68952-77-2 |
273-170-9 |
|
591 |
Tail gas (petroleum), catalytic hydrodesulfurised naphtha separator, if it contains > 0,1 % w/w Butadiene |
68952-79-4 |
273-173-5 |
|
592 |
Tail gas (petroleum), straight-run naphtha hydrodesulfurised, if it contains > 0,1 % w/w Butadiene |
68952-80-7 |
273-174-0 |
|
593 |
Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber, if it contains > 0,1 % w/w Butadiene |
68952-81-8 |
273-175-6 |
|
594 |
Tail gas (petroleum), thermal cracked hydrocarbon fractionation stabiliser, petroleum coking, if it contains > 0,1 % w/w Butadiene |
68952-82-9 |
273-176-1 |
|
595 |
Gases (petroleum), light steam-cracked, butadiene conc., if they contain > 0,1 % w/w Butadiene |
68955-28-2 |
273-265-5 |
|
596 |
Gases (petroleum), sponge absorber off, fluidised catalytic cracker and gas oil desulfuriser overhead fractionation, if they contain > 0,1 % w/w Butadiene |
68955-33-9 |
273-269-7 |
|
597 |
Gases (petroleum), straight-run naphtha catalytic reformer stabiliser overhead, if they contain > 0,1 % w/w Butadiene |
68955-34-0 |
273-270-2 |
|
598 |
Gases (petroleum), crude distn. and catalytic cracking, if they contain > 0,1 % w/w Butadiene |
68989-88-8 |
273-563-5 |
|
599 |
Hydrocarbons, C4, if they contain > 0,1 % w/w Butadiene |
87741-01-3 |
289-339-5 |
|
600 |
Alkanes, C1-4, C3-rich, if they contain > 0,1 % w/w Butadiene |
90622-55-2 |
292-456-4 |
|
601 |
Gases (petroleum), gas oil diethanolamine scrubber off, if they contain > 0,1 % w/w Butadiene |
92045-15-3 |
295-397-2 |
|
602 |
Gases (petroleum), gas oil hydrodesulfurisation effluent, if they contain > 0,1 % w/w Butadiene |
92045-16-4 |
295-398-8 |
|
603 |
Gases (petroleum), gas oil hydrodesulfurisation purge, if they contain > 0,1 % w/w Butadiene |
92045-17-5 |
295-399-3 |
|
604 |
Gases (petroleum), hydrogenator effluent flash drum off, if they contain > 0,1 % w/w Butadiene |
92045-18-6 |
295-400-7 |
|
605 |
Gases (petroleum), naphtha steam cracking high-pressure residual, if they contain > 0,1 % w/w Butadiene |
92045-19-7 |
295-401-2 |
|
606 |
Gases (petroleum), residue visbreaking off, if they contain > 0,1 % w/w Butadiene |
92045-20-0 |
295-402-8 |
|
607 |
Gases (petroleum), steam-cracker C3-rich, if they contain > 0,1 % w/w Butadiene |
92045-22-2 |
295-404-9 |
|
608 |
Hydrocarbons, C4, steam-cracker distillate, if they contain > 0,1 % w/w Butadiene |
92045-23-3 |
295-405-4 |
|
609 |
Petroleum gases, liquefied, sweetened, C4 fraction, if they contain > 0,1 % w/w Butadiene |
92045-80-2 |
295-463-0 |
|
610 |
Hydrocarbons, C4, 1,3-butadiene- and isobutene-free, if they contain > 0,1 % w/w Butadiene |
95465-89-7 |
306-004-1 |
|
611 |
Raffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free, if they contain > 0,1 % w/w Butadiene |
97722-19-5 |
307-769-4 |
|
612 |
Benzo[def]chrysene (benzo[a]pyrene) |
50-32-8 |
200-028-5 |
|
613 |
Pitch, coal tar-petroleum, if it contains > 0,005 % w/w benzo[a]pyrene |
68187-57-5 |
269-109-0 |
|
614 |
Distillates (coal-petroleum), condensed-ring arom., if they contain > 0,005 % w/w benzo[a]pyrene |
68188-48-7 |
269-159-3 |
|
615 |
Moved or deleted |
|
|
|
616 |
Moved or deleted |
|
|
|
617 |
Creosote oil, acenaphthene fraction, acenaphthene-free, if it contains > 0,005 % w/w benzo[a]pyrene |
90640-85-0 |
292-606-9 |
|
618 |
Pitch, coal tar, low-temp., if it contains > 0,005 % w/w benzo[a]pyrene |
90669-57-1 |
292-651-4 |
|
619 |
Pitch, coal tar, low-temp., heat-treated, if it contains > 0,005 % w/w benzo[a]pyrene |
90669-58-2 |
292-653-5 |
|
620 |
Pitch, coal tar, low-temp., oxidised, if it contains > 0,005 % w/w benzo[a]pyrene |
90669-59-3 |
292-654-0 |
|
621 |
Extract residues (coal), brown, if they contain > 0,005 % w/w benzo[a]pyrene |
91697-23-3 |
294-285-0 |
|
622 |
Paraffin waxes (coal), brown-coal high-temp. tar, if they contain > 0,005 % w/w benzo[a]pyrene |
92045-71-1 |
295-454-1 |
|
623 |
Paraffin waxes (coal), brown-coal high-temp. tar, hydrotreated, if they contain > 0,005 % w/w benzo[a]pyrene |
92045-72-2 |
295-455-7 |
|
624 |
Waste solids, coal-tar pitch coking, if they contain > 0,005 % w/w benzo[a]pyrene |
92062-34-5 |
295-549-8 |
|
625 |
Pitch, coal tar, high-temp., secondary, if it contains > 0,005 % w/w benzo[a]pyrene |
94114-13-3 |
302-650-3 |
|
626 |
Residues (coal), liq. solvent extn., if they contain > 0,005 % w/w benzo[a]pyrene |
94114-46-2 |
302-681-2 |
|
627 |
Coal liquids, liq. solvent extn. soln., if they contain > 0,005 % w/w benzo[a]pyrene |
94114-47-3 |
302-682-8 |
|
628 |
Coal liquids, liq. solvent extn., if they contain > 0,005 % w/w benzo[a]pyrene |
94114-48-4 |
302-683-3 |
|
629 |
Paraffin waxes (coal), brown-coal high-temp. tar, carbon-treated, if they contain > 0,005 % w/w benzo[a]pyrene |
97926-76-6 |
308-296-6 |
|
630 |
Paraffin waxes (coal), brown-coal high-temp tar, clay-treated, if they contain > 0,005 % w/w benzo[a]pyrene |
97926-77-7 |
308-297-1 |
|
631 |
Paraffin waxes (coal), brown-coal high-temp tar, silicic acid-treated, if they contain > 0,005 % w/w benzo[a]pyrene |
97926-78-8 |
308-298-7 |
|
632 |
Absorption oils, bicyclo arom. and heterocylic hydrocarbon fraction, if they contain > 0,005 % w/w benzo[a]pyrene |
101316-45-4 |
309-851-5 |
|
633 |
Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene polypropylene pyrolysis-derived, if they contain > 0,005 % w/w benzo[a]pyrene |
101794-74-5 |
309-956-6 |
|
634 |
Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene pyrolysis-derived, if they contain > 0,005 % w/w benzo[a]pyrene |
101794-75-6 |
309-957-1 |
|
635 |
Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polystyrene pyrolysis-derived, if they contain > 0,005 % w/w benzo[a]pyrene |
101794-76-7 |
309-958-7 |
|
636 |
Pitch, coal tar, high-temp., heat-treated, if it contains > 0,005 % w/w benzo[a]pyrene |
121575-60-8 |
310-162-7 |
|
637 |
Dibenz[a,h]anthracene |
53-70-3 |
200-181-8 |
|
638 |
Benz[a]anthracene |
56-55-3 |
200-280-6 |
|
639 |
Benzo[e]pyrene |
192-97-2 |
205-892-7 |
|
640 |
Benzo[j]fluoranthene |
205-82-3 |
205-910-3 |
|
641 |
Benz(e)acephenanthrylene |
205-99-2 |
205-911-9 |
|
642 |
Benzo(k)fluoranthene |
207-08-9 |
205-916-6 |
|
643 |
Chrysene |
218-01-9 |
205-923-4 |
|
644 |
2-Bromopropane |
75-26-3 |
200-855-1 |
|
645 |
Trichloroethylene |
79-01-6 |
201-167-4 |
|
646 |
1,2-Dibromo-3-chloropropane |
96-12-8 |
202-479-3 |
|
647 |
2,3-Dibromopropan-1-ol |
96-13-9 |
202-480-9 |
|
648 |
1,3-Dichloropropan-2-ol |
96-23-1 |
202-491-9 |
|
649 |
α,α,α-Trichlorotoluene |
98-07-7 |
202-634-5 |
|
650 |
α-Chlorotoluene (Benzyl chloride) |
100-44-7 |
202-853-6 |
|
651 |
1,2-Dibromoethane |
106-93-4 |
203-444-5 |
|
652 |
Hexachlorobenzene |
118-74-1 |
204-273-9 |
|
653 |
Bromoethylene (Vinyl bromide) |
593-60-2 |
209-800-6 |
|
654 |
1,4-Dichlorobut-2-ene |
764-41-0 |
212-121-8 |
|
655 |
Methyloxirane (Propylene oxide) |
75-56-9 |
200-879-2 |
|
656 |
(Epoxyethyl)benzene (Styrene oxide) |
96-09-3 |
202-476-7 |
|
657 |
1-Chloro-2,3-epoxypropane (Epichlorohydrin) |
106-89-8 |
203-439-8 |
|
658 |
R-1-Chloro-2,3-epoxypropane |
51594-55-9 |
424-280-2 |
|
659 |
1,2-Epoxy-3-phenoxypropane (Phenylglycidyl ether) |
122-60-1 |
204-557-2 |
|
660 |
2,3-Epoxypropan-1-ol (Glycidol) |
556-52-5 |
209-128-3 |
|
661 |
R-2,3-Epoxy-1-propanol |
57044-25-4 |
404-660-4 |
|
662 |
2,2′-Bioxirane (1,2:3,4-Diepoxybutane) |
1464-53-5 |
215-979-1 |
|
663 |
(2RS,3RS)-3-(2-Chlorophenyl)-2-(4-fluorophenyl)-[1H-1,2,4-triazol-1-yl)methyl]oxirane; Epoxiconazole |
133855-98-8 |
406-850-2 |
|
664 |
Chloromethyl methyl ether |
107-30-2 |
203-480-1 |
|
665 |
2-Methoxyethanol and its acetate (2-Methoxyethyl acetate) |
109-86-4/110-49-6 |
203-713-7/203-772-9 |
|
666 |
2-Ethoxyethanol and its acetate (2-Ethoxyethyl acetate) |
110-80-5/111-15-9 |
203-804-1/203-839-2 |
|
667 |
Oxybis[chloromethane], bis (Chloromethyl) ether |
542-88-1 |
208-832-8 |
|
668 |
2-Methoxypropanol |
1589-47-5 |
216-455-5 |
|
669 |
Propiolactone |
57-57-8 |
200-340-1 |
|
670 |
Dimethylcarbamoyl chloride |
79-44-7 |
201-208-6 |
|
671 |
Urethane (Ethyl carbamate) |
51-79-6 |
200-123-1 |
|
672 |
Moved or deleted |
|
|
|
673 |
Moved or deleted |
|
|
|
674 |
Methoxyacetic acid |
625-45-6 |
210-894-6 |
|
675 |
Dibutyl phthalate |
84-74-2 |
201-557-4 |
|
676 |
bis(2-Methoxyethyl) ether (Dimethoxydiglycol) |
111-96-6 |
203-924-4 |
|
677 |
bis(2-Ethylhexyl) phthalate (Diethylhexyl phthalate) |
117-81-7 |
204-211-0 |
|
678 |
bis(2-Methoxyethyl) phthalate |
117-82-8 |
204-212-6 |
|
679 |
2-Methoxypropyl acetate |
70657-70-4 |
274-724-2 |
|
680 |
2-Ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-methyl]thio]acetate |
80387-97-9 |
279-452-8 |
|
681 |
Acrylamide, unless regulated elsewhere in this Regulation |
79-06-1 |
201-173-7 |
|
682 |
Acrylonitrile |
107-13-1 |
203-466-5 |
|
683 |
2-Nitropropane |
79-46-9 |
201-209-1 |
|
684 |
Dinoseb, its salts and esters with the exception of those specified elsewhere in this list |
88-85-7 |
201-861-7 |
|
685 |
2-Nitroanisole |
91-23-6 |
202-052-1 |
|
686 |
4-Nitrobiphenyl |
92-93-3 |
202-204-7 |
|
687 |
2,4-Dinitrotoluene; Dinitrotoluene, technical grade |
121-14-2/25321-14-6 |
204-450-0/246-836-1 |
|
688 |
Binapacryl |
485-31-4 |
207-612-9 |
|
689 |
2-Nitronaphthalene |
581-89-5 |
209-474-5 |
|
690 |
2,3-Dinitrotoluene |
602-01-7 |
210-013-5 |
|
691 |
5-Nitroacenaphthene |
602-87-9 |
210-025-0 |
|
692 |
2,6-Dinitrotoluene |
606-20-2 |
210-106-0 |
|
693 |
3,4-Dinitrotoluene |
610-39-9 |
210-222-1 |
|
694 |
3,5-Dinitrotoluene |
618-85-9 |
210-566-2 |
|
695 |
2,5-Dinitrotoluene |
619-15-8 |
210-581-4 |
|
696 |
Dinoterb, its salts and esters |
1420-07-1 |
215-813-8 |
|
697 |
Nitrofen |
1836-75-5 |
217-406-0 |
|
698 |
Moved or deleted |
|
|
|
699 |
Diazomethane |
334-88-3 |
206-382-7 |
|
700 |
1,4,5,8-Tetraaminoanthraquinone (Disperse Blue 1) |
2475-45-8 |
219-603-7 |
|
701 |
Moved or deleted |
|
|
|
702 |
1-Methyl-3-nitro-1-nitrosoguanidine |
70-25-7 |
200-730-1 |
|
703 |
Moved or deleted |
|
|
|
704 |
Moved or deleted |
|
|
|
705 |
4,4′-Methylenedianiline |
101-77-9 |
202-974-4 |
|
706 |
4,4′-(4-Iminocyclohexa-2,5-dienylidenemethylene) dianiline hydrochloride |
569-61-9 |
209-321-2 |
|
707 |
4,4′-Methylenedi-o-toluidine |
838-88-0 |
212-658-8 |
|
708 |
o-Anisidine |
90-04-0 |
201-963-1 |
|
709 |
3,3′-Dimethoxybenzidine (ortho-Dianisidine) and its salts |
119-90-4 |
204-355-4 |
|
710 |
Moved or deleted |
|
|
|
711 |
o-Dianisidine based azo dyes |
|
|
|
712 |
3,3′-Dichlorobenzidine |
91-94-1 |
202-109-0 |
|
713 |
Benzidine dihydrochloride |
531-85-1 |
208-519-6 |
|
714 |
[[1,1′-Biphenyl]-4,4′-diyl]diammonium sulphate |
531-86-2 |
208-520-1 |
|
715 |
3,3′-Dichlorobenzidine dihydrochloride |
612-83-9 |
210-323-0 |
|
716 |
Benzidine sulphate |
21136-70-9 |
244-236-4 |
|
717 |
Benzidine acetate |
36341-27-2 |
252-984-8 |
|
718 |
3,3′-Dichlorobenzidine dihydrogen bis(sulphate) |
64969-34-2 |
265-293-1 |
|
719 |
3,3′-Dichlorobenzidine sulphate |
74332-73-3 |
277-822-3 |
|
720 |
Benzidine based azo dyes |
|
|
|
721 |
4,4′-Bi-o-toluidine (ortho-Tolidine) |
119-93-7 |
204-358-0 |
|
722 |
4,4′-Bi-o-toluidine dihydrochloride |
612-82-8 |
210-322-5 |
|
723 |
[3,3′-Dimethyl[1,1′-biphenyl]-4,4′-diyl]diammonium bis(hydrogen sulphate) |
64969-36-4 |
265-294-7 |
|
724 |
4,4′-Bi-o-toluidine sulphate |
74753-18-7 |
277-985-0 |
|
725 |
o-Tolidine based dyes |
|
611-030-00-4 |
|
726 |
Biphenyl-4-ylamine (4-Aminobiphenyl) and its salts |
92-67-1 |
202-177-1 |
|
727 |
Azobenzene |
103-33-3 |
203-102-5 |
|
728 |
(Methyl-ONN-azoxy)methyl acetate |
592-62-1 |
209-765-7 |
|
729 |
Cycloheximide |
66-81-9 |
200-636-0 |
|
730 |
2-Methylaziridine |
75-55-8 |
200-878-7 |
|
731 |
Imidazolidine-2-thione (Ethylene thiourea) |
96-45-7 |
202-506-9 |
|
732 |
Furan |
110-00-9 |
203-727-3 |
|
733 |
Aziridine |
151-56-4 |
205-793-9 |
|
734 |
Captafol |
2425-06-1 |
219-363-3 |
|
735 |
Carbadox |
6804-07-5 |
229-879-0 |
|
736 |
Flumioxazin |
103361-09-7 |
613-166-00-X |
|
737 |
Tridemorph |
24602-86-6 |
246-347-3 |
|
738 |
Vinclozolin |
50471-44-8 |
256-599-6 |
|
739 |
Fluazifop-butyl |
69806-50-4 |
274-125-6 |
|
740 |
Flusilazole |
85509-19-9 |
014-017-00-6 |
|
741 |
1,3,5-Tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione (TGIC) |
2451-62-9 |
219-514-3 |
|
742 |
Thioacetamide |
62-55-5 |
200-541-4 |
|
743 |
Moved or deleted |
|
|
|
744 |
Formamide |
75-12-7 |
200-842-0 |
|
745 |
N-Methylacetamide |
79-16-3 |
201-182-6 |
|
746 |
N-Methylformamide |
123-39-7 |
204-624-6 |
|
747 |
N,N-Dimethylacetamide |
127-19-5 |
204-826-4 |
|
748 |
Hexamethylphosphoric-triamide |
680-31-9 |
211-653-8 |
|
749 |
Diethyl sulphate |
64-67-5 |
200-589-6 |
|
750 |
Dimethyl sulphate |
77-78-1 |
201-058-1 |
|
751 |
1,3-Propanesultone |
1120-71-4 |
214-317-9 |
|
752 |
Dimethylsulphamoyl-chloride |
13360-57-1 |
236-412-4 |
|
753 |
Sulfallate |
95-06-7 |
202-388-9 |
|
754 |
A mixture of: 4-[[bis-(4-Fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole and 1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole |
|
403-250-2 |
|
755 |
(+/–)-Tetrahydrofurfuryl –(R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate |
119738-06-6 |
607-373-00-4 |
|
756 |
6-Hydroxy-1-(3-Isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridinecarbonitrile |
85136-74-9 |
-400-340-3 |
|
757 |
(6-(4-Hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazine-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate |
108225-03-2 |
402-060-7 |
|
758 |
Trisodium [4′-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4″-(6-benzoylamino-3-Sulfonato-2-naphthylazo)-biphenyl-1,3′,3″,1′′′-tetraolato-O,O′,O″,O′′′]copper(II) |
|
413-590-3 |
|
759 |
A mixture of: N-[3-Hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide and N-[2,3-bis-(2-Methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide and methacrylamide and 2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide and N-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide |
|
412-790-8 |
|
760 |
1,3,5-tris-[(2S and 2R)-2,3-Epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione (Teroxirone) |
59653-74-6 |
616-091-00-0 |
|
761 |
Erionite |
12510-42-8 |
650-012-00-0 |
|
762 |
Asbestos |
12001-28-4 |
650-013-00-6 |
|
763 |
Petroleum |
8002-05-9 |
232-298-5 |
|
764 |
Distillates (petroleum), heavy hydrocracked, if they contain > 3 % w/w DMSO extract |
64741-76-0 |
265-077-7 |
|
765 |
Distillates (petroleum), solvent-refined heavy paraffinic, if they contain > 3 % w/w DMSO extract |
64741-88-4 |
265-090-8 |
|
766 |
Distillates (petroleum), solvent-refined light paraffinic, if they contain > 3 % w/w DMSO extract |
64741-89-5 |
265-091-3 |
|
767 |
Residual oils (petroleum), solvent deasphalted, if they contain > 3 % w/w DMSO extract |
64741-95-3 |
265-096-0 |
|
768 |
Distillates (petroleum), solvent-refined heavy naphthenic, if they contain > 3 % w/w DMSO extract |
64741-96-4 |
265-097-6 |
|
769 |
Distillates (petroleum), solvent-refined light naphthenic, if they contain > 3 % w/w DMSO extract |
64741-97-5 |
265-098-1 |
|
770 |
Residual oils (petroleum), solvent-refined, if they contain > 3 % w/w DMSO extract |
64742-01-4 |
265-101-6 |
|
771 |
Distillates (petroleum), clay-treated heavy paraffinic, if they contain > 3 % w/w DMSO extract |
64742-36-5 |
265-137-2 |
|
772 |
Distillates (petroleum), clay-treated light paraffinic, if they contain > 3 % w/w DMSO extract |
64742-37-6 |
265-138-8 |
|
773 |
Residual oils (petroleum), clay-treated, if they contain > 3 % w/w DMSO extract |
64742-41-2 |
265-143-5 |
|
774 |
Distillates (petroleum), clay-treated heavy naphthenic, if they contain > 3 % w/w DMSO extract |
64742-44-5 |
265-146-1 |
|
775 |
Distillates (petroleum), clay-treated light naphthenic, if they contain > 3 % w/w DMSO extract |
64742-45-6 |
265-147-7 |
|
776 |
Distillates (petroleum), hydrotreated heavy naphthenic, if they contain > 3 % w/w DMSO extract |
64742-52-5 |
265-155-0 |
|
777 |
Distillates (petroleum), hydrotreated light naphthenic, if they contain > 3 % w/w DMSO extract |
64742-53-6 |
265-156-6 |
|
778 |
Distillates (petroleum), hydrotreated heavy paraffinic, if they contain > 3 % w/w DMSO extract |
64742-54-7 |
265-157-1 |
|
779 |
Distillates (petroleum), hydrotreated light paraffinic, if they contain > 3 % w/w DMSO extract |
64742-55-8 |
265-158-7 |
|
780 |
Distillates (petroleum), solvent-dewaxed light paraffinic, if they contain > 3 % w/w DMSO extract |
64742-56-9 |
265-159-2 |
|
781 |
Residual oils (petroleum), hydrotreated, if they contain > 3 % w/w DMSO extract |
64742-57-0 |
265-160-8 |
|
782 |
Residual oils (petroleum), solvent-dewaxed, if they contain > 3 % w/w DMSO extract |
64742-62-7 |
265-166-0 |
|
783 |
Distillates (petroleum), solvent-dewaxed heavy naphthenic, if they contain > 3 % w/w DMSO extract |
64742-63-8 |
265-167-6 |
|
784 |
Distillates (petroleum), solvent-dewaxed light naphthenic, if they contain > 3 % w/w DMSO extract |
64742-64-9 |
265-168-1 |
|
785 |
Distillates (petroleum), solvent-dewaxed heavy paraffinic, if they contain > 3 % w/w DMSO extract |
64742-65-0 |
265-169-7 |
|
786 |
Foots oil (petroleum), if it contains > 3 % w/w DMSO extract |
64742-67-2 |
265-171-8 |
|
787 |
Naphthenic oils (petroleum), catalytic dewaxed heavy, if they contain > 3 % w/w DMSO extract |
64742-68-3 |
265-172-3 |
|
788 |
Naphthenic oils (petroleum), catalytic dewaxed light, if they contain > 3 % w/w DMSO extract |
64742-69-4 |
265-173-9 |
|
789 |
Paraffin oils (petroleum), catalytic dewaxed heavy, if they contain > 3 % w/w DMSO extract |
64742-70-7 |
265-174-4 |
|
790 |
Paraffin oils (petroleum), catalytic dewaxed light, if they contain > 3 % w/w DMSO extract |
64742-71-8 |
265-176-5 |
|
791 |
Naphthenic oils (petroleum), complex dewaxed heavy, if they contain > 3 % w/w DMSO extract |
64742-75-2 |
265-179-1 |
|
792 |
Naphthenic oils (petroleum), complex dewaxed light, if they contain > 3 % w/w DMSO extract |
64742-76-3 |
265-180-7 |
|
793 |
Extracts (petroleum), heavy naphthenic distillate solvent, arom. Conc., if they contain > 3 % w/w DMSO extract |
68783-00-6 |
272-175-3 |
|
794 |
Extracts (petroleum), solvent-refined heavy paraffinic distillate solvent, if they contain > 3 % w/w DMSO extract |
68783-04-0 |
272-180-0 |
|
795 |
Extracts (petroleum), heavy paraffinic distillates, solvent-deasphalted, if they contain > 3 % w/w DMSO extract |
68814-89-1 |
272-342-0 |
|
796 |
Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based, high-viscosity, if they contain > 3 % w/w DMSO extract |
72623-85-9 |
276-736-3 |
|
797 |
Lubricating oils (petroleum), C15-30, hydrotreated neutral oil-based, if they contain > 3 % w/w DMSO extract |
72623- 86-0 |
276-737-9 |
|
798 |
Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based, if they contain > 3 % w/w DMSO extract |
72623- 87-1 |
276-738-4 |
|
799 |
Lubricating oils, if they contain > 3 % w/w DMSO extract |
74869-22-0 |
278-012-2 |
|
800 |
Distillates (petroleum), complex dewaxed heavy paraffinic, if they contain > 3 % w/w DMSO extract |
90640-91-8 |
292-613-7 |
|
801 |
Distillates (petroleum), complex dewaxed light paraffinic, if they contain > 3 % w/w DMSO extract |
90640-92-9 |
292-614-2 |
|
802 |
Distillates (petroleum), solvent dewaxed heavy paraffinic, clay-treated, if they contain > 3 % w/w DMSO extract |
90640-94-1 |
292-616-3 |
|
803 |
Hydrocarbons, C20-50, solvent dewaxed heavy paraffinic, hydrotreated, if they contain > 3 % w/w DMSO extract |
90640-95-2 |
292-617-9 |
|
804 |
Distillates (petroleum), solvent dewaxed light paraffinic, clay-treated, if they contain > 3 % w/w DMSO extract |
90640-96-3 |
292-618-4 |
|
805 |
Distillates (petroleum), solvent dewaxed light paraffinic, hydrotreated, if they contain > 3 % w/w DMSO extract |
90640-97-4 |
292-620-5 |
|
806 |
Extracts (petroleum), heavy naphthenic distillate solvent, hydrotreated, if they contain > 3 % w/w DMSO extract |
90641-07-9 |
292-631-5 |
|
807 |
Extracts (petroleum), heavy paraffinic distillate solvent, hydrotreated, if they contain > 3 % w/w DMSO extract |
90641-08-0 |
292-632-0 |
|
808 |
Extracts (petroleum), light paraffinic distillate solvent, hydrotreated, if they contain > 3 % w/w DMSO extract |
90641-09-1 |
292-633-6 |
|
809 |
Residual oils (petroleum), hydrotreated solvent dewaxed, if they contain > 3 % w/w DMSO extract |
90669-74-2 |
292-656-1 |
|
810 |
Residual oils (petroleum), catalytic dewaxed, if they contain > 3 % w/w DMSO extract |
91770-57-9 |
294-843-3 |
|
811 |
Distillates (petroleum), dewaxed heavy paraffinic, hydrotreated, if they contain > 3 % w/w DMSO extract |
91995-39-0 |
295-300-3 |
|
812 |
Distillates (petroleum), dewaxed light paraffinic, hydrotreated, if they contain > 3 % w/w DMSO extract |
91995-40-3 |
295-301-9 |
|
813 |
Distillates (petroleum), hydrocracked solvent-refined, dewaxed, if they contain > 3 % w/w DMSO extract |
91995-45-8 |
295-306-6 |
|
814 |
Distillates (petroleum), solvent-refined light naphthenic, hydrotreated, if they contain > 3 % w/w DMSO extract |
91995-54-9 |
295-316-0 |
|
815 |
Extracts (petroleum), hydrotreated light paraffinic distillate solvent, if they contain > 3 % w/w DMSO extract |
91995- 73-2 |
295-335-4 |
|
816 |
Extracts (petroleum), light naphthenic distillate solvent, hydrodesulfurised, if they contain > 3 % w/w DMSO extract |
91995-75-4 |
295-338-0 |
|
817 |
Extracts (petroleum), light paraffinic distillate solvent, acid-treated, if they contain > 3 % w/w DMSO extract |
91995-76-5 |
295-339-6 |
|
818 |
Extracts (petroleum), light paraffinic distillate solvent, hydrodesulfurised, if they contain > 3 % w/w DMSO extract |
91995-77-6 |
295-340-1 |
|
819 |
Extracts (petroleum), light vacuum gas oil solvent, hydrotreated, if they contain > 3 % w/w DMSO extract |
91995-79-8 |
295-342-2 |
|
820 |
Foots oil (petroleum), hydrotreated, if it contains > 3 % w/w DMSO extract |
92045-12-0 |
295-394-6 |
|
821 |
Lubricating oils (petroleum), C17-35, solvent-extd., dewaxed, hydrotreated, if they contain > 3 % w/w DMSO extract |
92045-42-6 |
295-423-2 |
|
822 |
Lubricating oils (petroleum), hydrocracked nonarom solvent-deparaffined, if they contain > 3 % w/w DMSO extract |
92045-43-7 |
295-424-8 |
|
823 |
Residual oils (petroleum), hydrocracked acid-treated solvent-dewaxed, if they contain > 3 % w/w DMSO extract |
92061-86-4 |
295-499-7 |
|
824 |
Paraffin oils (petroleum), solvent-refined dewaxed heavy, if they contain > 3 % w/w DMSO extract |
92129-09-4 |
295-810-6 |
|
825 |
Extracts (petroleum), heavy paraffinic distillate solvent, clay-treated, if they contain > 3 % w/w DMSO extract |
92704-08-0 |
296-437-1 |
|
826 |
Lubricating oils (petroleum), base oils, paraffinic, if they contain > 3 % w/w DMSO extract |
93572-43-1 |
297-474-6 |
|
827 |
Extracts (petroleum), heavy naphthenic distillate solvent, hydrodesulfurised, if they contain > 3 % w/w DMSO extract |
93763-10-1 |
297-827-4 |
|
828 |
Extracts (petroleum), solvent-dewaxed heavy paraffinic distillate solvent, hydrodesulfurised, if they contain > 3 % w/w DMSO extract |
93763-11-2 |
297-829-5 |
|
829 |
Hydrocarbons, hydrocracked paraffinic distn. residues, solvent-dewaxed, if they contain > 3 % w/w DMSO extract |
93763-38-3 |
297-857-8 |
|
830 |
Foots oil (petroleum), acid-treated, if it contains > 3 % w/w DMSO extract |
93924-31-3 |
300-225-7 |
|
831 |
Foots oil (petroleum), clay-treated, if it contains > 3 % w/w DMSO extract |
93924-32-4 |
300-226-2 |
|
832 |
Hydrocarbons, C20-50, residual oil hydrogenation vacuum distillate, if they contain > 3 % w/w DMSO extract |
93924-61-9 |
300-257-1 |
|
833 |
Distillates (petroleum), solvent-refined hydrotreated heavy, hydrogenated, if they contain > 3 % w/w DMSO extract |
94733-08-1 |
305-588-5 |
|
834 |
Distillates (petroleum), solvent-refined hydrocracked light, if they contain > 3 % w/w DMSO extract |
94733-09-2 |
305-589-0 |
|
835 |
Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrocracked distillate-based, if they contain > 3 % w/w DMSO extract |
94733-15-0 |
305-594-8 |
|
836 |
Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrogenated raffinate-based, if they contain > 3 % w/w DMSO extract |
94733-16-1 |
305-595-3 |
|
837 |
Hydrocarbons, C13-30, arom. -rich, solvent-extd. naphthenic distillate, if they contain > 3 % w/w DMSO extract |
95371-04-3 |
305-971-7 |
|
838 |
Hydrocarbons, C16-32, arom. rich, solvent-extd. naphthenic distillate, if they contain > 3 % w/w DMSO extract |
95371-05-4 |
305-972-2 |
|
839 |
Hydrocarbons, C37-68, dewaxed deasphalted hydrotreated vacuum distn. Residues, if they contain > 3 % w/w DMSO extract |
95371-07-6 |
305-974-3 |
|
840 |
Hydrocarbons, C37-65, hydrotreated deasphalted vacuum distn. Residues, if they contain > 3 % w/w DMSO extract |
95371-08-7 |
305-975-9 |
|
841 |
Distillates (petroleum), hydrocracked solvent-refined light, if they contain > 3 % w/w DMSO extract |
97488-73-8 |
307-010-7 |
|
842 |
Distillates (petroleum), solvent-refined hydrogenated heavy, if they contain > 3 % w/w DMSO extract |
97488-74-9 |
307-011-2 |
|
843 |
Lubricating oils (petroleum), C18-27, hydrocracked solvent-dewaxed, if they contain > 3 % w/w DMSO extract |
97488-95-4 |
307-034-8 |
|
844 |
Hydrocarbons, C17-30, hydrotreated solvent-deasphalted atm. distn. residue, distn. lights, if they contain > 3 % w/w DMSO extract |
97675-87-1 |
307-661-7 |
|
845 |
Hydrocarbons, C17-40, hydrotreated solvent-deasphalted distn. residue, vacuum distn. lights, if they contain > 3 % w/w DMSO extract |
97722-06-0 |
307-755-8 |
|
846 |
Hydrocarbons, C13-27, solvent-extd. light naphthenic, if they contain > 3 % w/w DMSO extract |
97722-09-3 |
307-758-4 |
|
847 |
Hydrocarbons, C14-29, solvent-extd. light naphthenic, if they contain > 3 % w/w DMSO extract |
97722-10-6 |
307-760-5 |
|
848 |
Foots oil (petroleum), carbon-treated, if it contains > 3 % w/w DMSO extract |
97862-76-5 |
308-126-0 |
|
849 |
Foots oil (petroleum), silicic acid-treated, if it contains > 3 % w/w DMSO extract |
97862-77-6 |
308-127-6 |
|
850 |
Hydrocarbons, C27-42, dearomatised, if they contain > 3 % w/w DMSO extract |
97862-81-2 |
308-131-8 |
|
851 |
Hydrocarbons, C17-30, hydrotreated distillates, distn. Lights, if they contain > 3 % w/w DMSO extract |
97862-82-3 |
308-132-3 |
|
852 |
Hydrocarbons, C27-45, naphthenic vacuum distn., if they contain > 3 % w/w DMSO extract |
97862-83-4 |
308-133-9 |
|
853 |
Hydrocarbons, C27-45, dearomatised, if they contain > 3 % w/w DMSO extract |
97926-68-6 |
308-287-7 |
|
854 |
Hydrocarbons, C20-58, hydrotreated, if they contain > 3 % w/w DMSO extract |
97926-70-0 |
308-289-8 |
|
855 |
Hydrocarbons, C27-42, naphthenic, if they contain > 3 % w/w DMSO extract |
97926-71-1 |
308-290-3 |
|
856 |
Extracts (petroleum), light paraffinic distillate solvent, carbon-treated, if they contain > 3 % w/w DMSO extract |
100684-02-4 |
309-672-2 |
|
857 |
Extracts (petroleum), light paraffinic distillate solvent, clay-treated, if they contain > 3 % w/w DMSO extract |
100684- 03-5 |
309-673-8 |
|
858 |
Extracts (petroleum), light vacuum, gas oil solvent, carbon-treated, if they contain > 3 % w/w DMSO extract |
100684-04-6 |
309-674-3 |
|
859 |
Extracts (petroleum), light vacuum gas oil solvent, clay-treated, if they contain > 3 % w/w DMSO extract |
100684-05-7 |
309-675-9 |
|
860 |
Residual oils (petroleum), carbon-treated solvent-dewaxed, if they contain > 3 % w/w DMSO extract |
100684-37-5 |
309-710-8 |
|
861 |
Residual oils (petroleum), clay-treated solvent-dewaxed, if they contain > 3 % w/w DMSO extract |
100684-38-6 |
309-711-3 |
|
862 |
Lubricating oils (petroleum), C>25, solvent-extd., deasphalted, dewaxed, hydrogenated, if they contain > 3 % w/w DMSO extract |
101316-69-2 |
309-874-0 |
|
863 |
Lubricating oils (petroleum), C17-32, solvent-extd., dewaxed, hydrogenated, if they contain > 3 % w/w DMSO extract |
101316-70-5 |
309-875-6 |
|
864 |
Lubricating oils (petroleum), C20-35, solvent-extd., dewaxed, hydrogenated, if they contain > 3 % w/w DMSO extract |
101316-71-6 |
309-876-1 |
|
865 |
Lubricating oils (petroleum), C24-50, solvent-extd., dewaxed, hydrogenated, if they contain > 3 % w/w DMSO extract |
101316-72-7 |
309-877-7 |
|
866 |
Distillates (petroleum), sweetened middle, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
64741-86-2 |
265-088-7 |
|
867 |
Gas oils (petroleum), solvent-refined, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
64741-90-8 |
265-092-9 |
|
868 |
Distillates (petroleum), solvent-refined middle, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
64741-91-9 |
265-093-4 |
|
869 |
Gas oils (petroleum), acid-treated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
64742-12-7 |
265-112-6 |
|
870 |
Distillates (petroleum), acid-treated middle, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
64742-13-8 |
265-113-1 |
|
871 |
Distillates (petroleum), acid-treated light, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
64742-14-9 |
265-114-7 |
|
872 |
Gas oils (petroleum), chemically neutralised, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
64742-29-6 |
265-129-9 |
|
873 |
Distillates (petroleum), chemically neutralised middle, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
64742-30-9 |
265-130-4 |
|
874 |
Distillates (petroleum), clay-treated middle, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
64742-38-7 |
265-139-3 |
|
875 |
Distillates (petroleum), hydrotreated middle, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
64742-46-7 |
265-148-2 |
|
876 |
Gas oils (petroleum), hydrodesulfurised, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
64742-79-6 |
265-182-8 |
|
877 |
Distillates (petroleum), hydrodesulfurised middle, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
64742-80-9 |
265-183-3 |
|
878 |
Distillates (petroleum), catalytic reformer fractionator residue, high-boiling, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
68477-29-2 |
270-719-4 |
|
879 |
Distillates (petroleum), catalytic reformer fractionator residue, intermediate-boiling, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
68477-30-5 |
270-721-5 |
|
880 |
Distillates (petroleum), catalytic reformer fractionator residue, low-boiling, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
68477-31-6 |
270-722-0 |
|
881 |
Alkanes, C12-26, branched and linear, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
90622-53-0 |
292-454-3 |
|
882 |
Distillates (petroleum), highly refined middle, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
90640-93-0 |
292-615-8 |
|
883 |
Distillates (petroleum), catalytic reformer, heavy arom. conc., except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
91995-34-5 |
295-294-2 |
|
884 |
Gas oils, paraffinic, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
93924-33-5 |
300-227-8 |
|
885 |
Naphtha (petroleum), solvent-refined hydrodesulfurised heavy, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
97488-96-5 |
307-035-3 |
|
886 |
Hydrocarbons, C16-20, hydrotreated middle distillate, distn. Lights, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
97675- 85-9 |
307-659-6 |
|
887 |
Hydrocarbons, C12-20, hydrotreated paraffinic, distn. lights, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
97675-86-0 |
307-660-1 |
|
888 |
Hydrocarbons, C11-17, solvent-extd. light naphthenic, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
97722-08-2 |
307-757-9 |
|
889 |
Gas oils, hydrotreated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
97862-78-7 |
308-128-1 |
|
890 |
Distillates (petroleum), carbon-treated light paraffinic, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
100683-97-4 |
309-667-5 |
|
891 |
Distillates (petroleum), intermediate paraffinic, carbon-treated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
100683-98-5 |
309-668-0 |
|
892 |
Distillates (petroleum), intermediate paraffinic, clay-treated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
100683-99-6 |
309-669-6 |
|
893 |
Lubricating greases, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
74869-21-9 |
278-011-7 |
|
894 |
Slack wax (petroleum), except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
64742-61-6 |
265-165-5 |
|
895 |
Slack wax (petroleum), acid-treated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
90669-77-5 |
292-659-8 |
|
896 |
Slack wax (petroleum), clay-treated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
90669-78-6 |
292-660-3 |
|
897 |
Slack wax (petroleum), hydrotreated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
92062-09-4 |
295-523-6 |
|
898 |
Slack wax (petroleum), low-melting, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
92062-10-7 |
295-524-1 |
|
899 |
Slack wax (petroleum), low-melting, hydrotreated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
92062-11-8 |
295-525-7 |
|
900 |
Slack wax (petroleum), low-melting, carbon-treated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
97863-04-2 |
308-155-9 |
|
901 |
Slack wax (petroleum), low-melting, clay-treated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
97863-05-3 |
308-156-4 |
|
902 |
Slack wax (petroleum), low-melting, silicic acid-treated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
97863-06-4 |
308-158-5 |
|
903 |
Slack wax (petroleum), carbon-treated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
100684-49-9 |
309-723-9 |
|
904 |
Petrolatum, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
8009-03-8 |
232-373-2 |
|
905 |
Petrolatum (petroleum), oxidised, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
64743-01-7 |
265-206-7 |
|
906 |
Petrolatum (petroleum), alumina-treated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
85029-74-9 |
285-098-5 |
|
907 |
Petrolatum (petroleum), hydrotreated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
92045-77-7 |
295-459-9 |
|
908 |
Petrolatum (petroleum), carbon-treated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
97862-97-0 |
308-149-6 |
|
909 |
Petrolatum (petroleum), silicic acid-treated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
97862-98-1 |
308-150-1 |
|
910 |
Petrolatum (petroleum), clay-treated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen |
100684-33-1 |
309-706-6 |
|
911 |
Distillates (petroleum), light catalytic cracked |
64741-59-9 |
265-060-4 |
|
912 |
Distillates (petroleum), intermediate catalytic cracked |
64741-60-2 |
265-062-5 |
|
913 |
Distillates (petroleum), light thermal cracked |
64741-82-8 |
265-084-5 |
|
914 |
Distillates (petroleum), hydrodesulfurised light catalytic cracked |
68333-25-5 |
269-781-5 |
|
915 |
Distillates (petroleum), light steam-cracked naphtha |
68475-80-9 |
270-662-5 |
|
916 |
Distillates (petroleum), cracked steam-cracked petroleum distillates |
68477-38-3 |
270-727-8 |
|
917 |
Gas oils (petroleum), steam-cracked |
68527-18-4 |
271-260-2 |
|
918 |
Distillates (petroleum), hydrodesulfurised thermal cracked middle |
85116-53-6 |
285-505-6 |
|
919 |
Gas oils (petroleum), thermal-cracked, hydrodesulfurised |
92045-29-9 |
295-411-7 |
|
920 |
Residues (petroleum), hydrogenated steam-cracked naphtha |
92062-00-5 |
295-514-7 |
|
921 |
Residues (petroleum), steam-cracked naphtha distn. |
92062-04-9 |
295-517-3 |
|
922 |
Distillates (petroleum), light catalytic cracked, thermally degraded |
92201-60-0 |
295-991-1 |
|
923 |
Residues (petroleum), steam-cracked heat-soaked naphtha |
93763-85-0 |
297-905-8 |
|
924 |
Gas oils (petroleum), light vacuum, thermal-cracked hydrodesulfurised |
97926-59-5 |
308-278-8 |
|
925 |
Distillates (petroleum), hydrodesulfurised middle coker |
101316-59-0 |
309-865-1 |
|
926 |
Distillates (petroleum), heavy steam-cracked |
101631-14-5 |
309-939-3 |
|
927 |
Residues (petroleum), atm. Tower |
64741-45-3 |
265-045-2 |
|
928 |
Gas oils (petroleum), heavy vacuum |
64741-57-7 |
265-058-3 |
|
929 |
Distillates (petroleum), heavy catalytic cracked |
64741-61-3 |
265-063-0 |
|
930 |
Clarified oils (petroleum), catalytic cracked |
64741-62-4 |
265-064-6 |
|
931 |
Residues (petroleum), catalytic reformer fractionator |
64741-67-9 |
265-069-3 |
|
932 |
Residues (petroleum), hydrocracked |
64741-75-9 |
265-076-1 |
|
933 |
Residues (petroleum), thermal cracked |
64741-80-6 |
265-081-9 |
|
934 |
Distillates (petroleum), heavy thermal cracked |
64741-81-7 |
265-082-4 |
|
935 |
Gas oils (petroleum), hydrotreated vacuum |
64742-59-2 |
265-162-9 |
|
936 |
Residues (petroleum), hydrodesulfurised atmospheric tower |
64742-78-5 |
265-181-2 |
|
937 |
Gas oils (petroleum), hydrodesulfurised heavy vacuum |
64742-86-5 |
265-189-6 |
|
938 |
Residues (petroleum), steam-cracked |
64742-90-1 |
265-193-8 |
|
939 |
Residues (petroleum), atmospheric |
68333-22-2 |
269-777-3 |
|
940 |
Clarified oils (petroleum), hydrodesulfurised catalytic cracked |
68333-26-6 |
269-782-0 |
|
941 |
Distillates (petroleum), hydrodesulfurised intermediate catalytic cracked |
68333-27-7 |
269-783-6 |
|
942 |
Distillates (petroleum), hydrodesulfurised heavy catalytic cracked |
68333-28-8 |
269-784-1 |
|
943 |
Fuel oil, residues-straight-run gas oils, high-sulfur |
68476-32-4 |
270-674-0 |
|
944 |
Fuel oil, residual |
68476-33-5 |
270-675-6 |
|
945 |
Residues (petroleum), catalytic reformer fractionator residue distn. |
68478-13-7 |
270-792-2 |
|
946 |
Residues (petroleum), heavy coker gas oil and vacuum gas oil |
68478-17-1 |
270-796-4 |
|
947 |
Residues (petroleum), heavy coker and light vacuum |
68512-61-8 |
270-983-0 |
|
948 |
Residues (petroleum), light vacuum |
68512-62-9 |
270-984-6 |
|
949 |
Residues (petroleum), steam-cracked light |
68513-69-9 |
271-013-9 |
|
950 |
Fuel oil, No 6 |
68553-00-4 |
271-384-7 |
|
951 |
Residues (petroleum), topping plant, low-sulfur |
68607-30-7 |
271-763-7 |
|
952 |
Gas oils (petroleum), heavy atmospheric |
68783-08-4 |
272-184-2 |
|
953 |
Residues (petroleum), coker scrubber, condensed-ring-arom. -contg |
68783-13-1 |
272-187-9 |
|
954 |
Distillates (petroleum), petroleum residues vacuum |
68955-27-1 |
273-263-4 |
|
955 |
Residues (petroleum), steam-cracked, resinous |
68955-36-2 |
273-272-3 |
|
956 |
Distillates (petroleum), intermediate vacuum |
70592-76-6 |
274-683-0 |
|
957 |
Distillates (petroleum), light vacuum |
70592-77-7 |
274-684-6 |
|
958 |
Distillates (petroleum), vacuum |
70592-78-8 |
274-685-1 |
|
959 |
Gas oils (petroleum), hydrodesulfurised coker heavy vacuum |
85117-03-9 |
285-555-9 |
|
960 |
Residues (petroleum), steam-cracked, distillates |
90669-75-3 |
292-657-7 |
|
961 |
Residues (petroleum), vacuum, light |
90669-76-4 |
292-658-2 |
|
962 |
Fuel oil, heavy, high-sulfur |
92045-14-2 |
295-396-7 |
|
963 |
Residues (petroleum), catalytic cracking |
92061-97-7 |
295-511-0 |
|
964 |
Distillates (petroleum), intermediate catalytic cracked, thermally degraded |
92201-59-7 |
295-990-6 |
|
965 |
Residual oils (petroleum) |
93821-66-0 |
298-754-0 |
|
966 |
Residues, steam cracked, thermally treated |
98219-64-8 |
308-733-0 |
|
967 |
Distillates (petroleum), hydrodesulfurised full-range middle |
101316-57-8 |
309-863-0 |
|
968 |
Distillates (petroleum), light paraffinic |
64741-50-0 |
265-051-5 |
|
969 |
Distillates (petroleum), heavy paraffinic |
64741-51-1 |
265-052-0 |
|
970 |
Distillates (petroleum), light naphthenic |
64741-52-2 |
265-053-6 |
|
971 |
Distillates (petroleum), heavy naphthenic |
64741-53-3 |
265-054-1 |
|
972 |
Distillates (petroleum), acid-treated heavy naphthenic |
64742-18-3 |
265-117-3 |
|
973 |
Distillates (petroleum), acid-treated light naphthenic |
64742-19-4 |
265-118-9 |
|
974 |
Distillates (petroleum), acid-treated heavy paraffinic |
64742-20-7 |
265-119-4 |
|
975 |
Distillates (petroleum), acid-treated light paraffinic |
64742-21-8 |
265-121-5 |
|
976 |
Distillates (petroleum), chemically neutralised heavy paraffinic |
64742-27-4 |
265-127-8 |
|
977 |
Distillates (petroleum), chemically neutralised light paraffinic |
64742-28-5 |
265-128-3 |
|
978 |
Distillates (petroleum), chemically neutralised heavy naphthenic |
64742-34-3 |
265-135-1 |
|
979 |
Distillates (petroleum), chemically neutralised light naphthenic |
64742-35-4 |
265-136-7 |
|
980 |
Extracts (petroleum), light naphthenic distillate solvent |
64742-03-6 |
265-102-1 |
|
981 |
Extracts (petroleum), heavy paraffinic distillate solvent |
64742-04-7 |
265-103-7 |
|
982 |
Extracts (petroleum), light paraffinic distillate solvent |
64742-05-8 |
265-104-2 |
|
983 |
Extracts (petroleum), heavy naphthenic distillate solvent |
64742-11-6 |
265-111-0 |
|
984 |
Extracts (petroleum), light vacuum gas oil solvent |
91995-78-7 |
295-341-7 |
|
985 |
Hydrocarbons, C26-55, arom. rich |
97722-04-8 |
307-753-7 |
|
986 |
Disodium 3,3′-[[1,1′-biphenyl]-4,4′-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate) |
573-58-0 |
209-358-4 |
|
987 |
Disodium 4-amino-3-[[4′-[(2,4-diaminophenyl)azo] [1,1′-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulphonate |
1937-37-7 |
217-710-3 |
|
988 |
Tetrasodium 3,3′-[[1,1′-biphenyl]-4,4′-diylbis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate] |
2602-46-2 |
220-012-1 |
|
989 |
4-o-Tolylazo-o-toluidine |
97-56-3 |
202-591-2 |
|
990 |
4-Aminoazobenzene |
60-09-3 |
200-453-6 |
|
991 |
Disodium[5-[[4′-[[2,6-dihydroxy-3-[(2-hydroxy-5-sulphophenyl)azo]phenyl]azo][1,1′-biphenyl]-4-yl]azo]salicylato(4-)]cuprate(2-) |
16071-86-6 |
240-221-1 |
|
992 |
Resorcinol diglycidyl ether |
101-90-6 |
202-987-5 |
|
993 |
1,3-Diphenylguanidine |
102-06-7 |
203-002-1 |
|
994 |
Heptachlor-epoxide |
1024-57-3 |
213-831-0 |
|
995 |
4-Nitrosophenol |
104-91-6 |
203-251-6 |
|
996 |
Carbendazim |
10605-21-7 |
234-232-0 |
|
997 |
Allyl glycidyl ether |
106-92-3 |
203-442-4 |
|
998 |
Chloroacetaldehyde |
107-20-0 |
203-472-8 |
|
999 |
Hexane |
110-54-3 |
203-777-6 |
|
1000 |
2-(2-Methoxyethoxy)ethanol (Diethylene glycol monomethyl ether; DEGME) |
111-77-3 |
203-906-6 |
|
1001 |
(+/–)-2-(2,4-Dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether (Tetraconazole - ISO) |
112281-77-3 |
407-760-6 |
|
1002 |
4-[4-(1,3-Dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinone |
114565-66-1 |
406-057-1 |
|
1003 |
5,6,12,13-Tetrachloroanthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone |
115662-06-1 |
405-100-1 |
|
1004 |
tris(2-Chloroethyl) phosphate |
115-96-8 |
204-118-5 |
|
1005 |
4′-Ethoxy-2-benzimidazoleanilide |
120187-29-3 |
407-600-5 |
|
1006 |
Nickel dihydroxide |
12054-48-7 |
235-008-5 |
|
1007 |
N,N-Dimethylaniline |
121-69-7 |
204-493-5 |
|
1008 |
Simazine |
122-34-9 |
204-535-2 |
|
1009 |
bis(Cyclopentadienyl)-bis(2,6-difluoro-3-(pyrrol-1-yl)-phenyl)titanium |
125051-32-3 |
412-000-1 |
|
1010 |
N,N,N′,N′-Tetraglycidyl-4,4′-diamino-3,3′-diethyldiphenylmethane |
130728-76-6 |
410-060-3 |
|
1011 |
Divanadium pentaoxide |
1314-62-1 |
215-239-8 |
|
1012 |
Pentachlorophenol and its alkali salts |
87-86-5/131-52-2/7778-73-6 |
201-778-6/205-025-2/231-911-3 |
|
1013 |
Phosphamidon |
13171-21-6 |
236-116-5 |
|
1014 |
N-(Trichloromethylthio)phthalimide (Folpet - ISO) |
133-07-3 |
205-088-6 |
|
1015 |
N-2-Naphthylaniline |
135-88-6 |
205-223-9 |
|
1016 |
Ziram |
137-30-4 |
205-288-3 |
|
1017 |
1-Bromo-3,4,5-trifluorobenzene |
138526-69-9 |
418-480-9 |
|
1018 |
Propazine |
139-40-2 |
205-359-9 |
|
1019 |
3-(4-Chlorophenyl)-1,1-dimethyluronium trichloroacetate; monuron-TCA |
140-41-0 |
006-043-00-1 |
|
1020 |
Isoxaflutole |
141112-29-0 |
606-054-00-7 |
|
1021 |
Kresoxim-methyl |
143390-89-0 |
607-310-00-0 |
|
1022 |
Chlordecone |
143-50-0 |
205-601-3 |
|
1023 |
9-Vinylcarbazole |
1484-13-5 |
216-055-0 |
|
1024 |
2-Ethylhexanoic acid |
149-57-5 |
205-743-6 |
|
1025 |
Monuron |
150-68-5 |
205-766-1 |
|
1026 |
Morpholine-4-carbonyl chloride |
15159-40-7 |
239-213-0 |
|
1027 |
Daminozide |
1596-84-5 |
216-485-9 |
|
1028 |
Alachlor (ISO) |
15972-60-8 |
240-110-8 |
|
1029 |
UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine |
166242-53-1 |
422-720-8 |
|
1030 |
Ioxynil and Ioxynil octanoate (ISO) |
1689-83-4/3861-47-0 |
216-881-1/223-375-4 |
|
1031 |
Bromoxynil (ISO) (3,5-Dibromo-4-hydroxybenzonitrile) and Bromoxynil heptanoate (ISO) |
1689-84-5/56634-95-8 |
216-882-7/260-300-4 |
|
1032 |
2,6-Dibromo-4-cyanophenyl octanoate |
1689-99-2 |
216-885-3 |
|
1033 |
Moved or deleted |
|
|
|
1034 |
5-Chloro-1,3-dihydro-2H-indol-2-one |
17630-75-0 |
412-200-9 |
|
1035 |
Benomyl |
17804-35-2 |
241-775-7 |
|
1036 |
Chlorothalonil |
1897-45-6 |
217-588-1 |
|
1037 |
N′-(4-Chloro-o-tolyl)-N,N-dimethylformamidine monohydrochloride |
19750-95-9 |
243-269-1 |
|
1038 |
4,4′-Methylenebis(2-ethylaniline) |
19900-65-3 |
243-420-1 |
|
1039 |
Valinamide |
20108-78-5 |
402-840-7 |
|
1040 |
[(p-Tolyloxy)methyl]oxirane |
2186-24-5 |
218-574-8 |
|
1041 |
[(m-Tolyloxy)methyl]oxirane |
2186-25-6 |
218-575-3 |
|
1042 |
2,3-Epoxypropyl o-tolyl ether |
2210-79-9 |
218-645-3 |
|
1043 |
[(Tolyloxy)methyl]oxirane, cresyl glycidyl ether |
26447-14-3 |
247-711-4 |
|
1044 |
Di-allate |
2303-16-4 |
218-961-1 |
|
1045 |
Benzyl 2,4-dibromobutanoate |
23085-60-1 |
420-710-8 |
|
1046 |
Trifluoroiodomethane |
2314-97-8 |
219-014-5 |
|
1047 |
Thiophanate-methyl |
23564-05-8 |
245-740-7 |
|
1048 |
Dodecachloropentacyclo[5.2.1.02,6.03,905,8]decane (Mirex) |
2385-85-5 |
219-196-6 |
|
1049 |
Propyzamide |
23950-58-5 |
245-951-4 |
|
1050 |
Butyl glycidyl ether |
2426-08-6 |
219-376-4 |
|
1051 |
2,3,4-Trichlorobut-1-ene |
2431-50-7 |
219-397-9 |
|
1052 |
Chinomethionate |
2439-01-2 |
219-455-3 |
|
1053 |
(R)-α-Phenylethylammonium (-)-(1R,2S)-(1,2-epoxypropyl)phosphonate monohydrate |
25383-07-7 |
418-570-8 |
|
1054 |
5-Ethoxy-3-trichloromethyl-1,2,4-thiadiazole (Etridiazole - ISO) |
2593-15-9 |
219-991-8 |
|
1055 |
Disperse Yellow 3 |
2832-40-8 |
220-600-8 |
|
1056 |
1,2,4-Triazole |
288-88-0 |
206-022-9 |
|
1057 |
Aldrin (ISO) |
309-00-2 |
206-215-8 |
|
1058 |
Diuron (ISO) |
330-54-1 |
206-354-4 |
|
1059 |
Linuron (ISO) |
330-55-2 |
206-356-5 |
|
1060 |
Nickel carbonate |
3333-67-3 |
222-068-2 |
|
1061 |
3-(4-Isopropylphenyl)-1,1-dimethylurea (Isoproturon - ISO) |
34123-59-6 |
251-835-4 |
|
1062 |
Iprodione |
36734-19-7 |
253-178-9 |
|
1063 |
Moved or deleted |
|
|
|
1064 |
5-(2,4-Dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluoro-2-hydroxymethyltetrahydrofuran |
41107-56-6 |
415-360-8 |
|
1065 |
Crotonaldehyde |
4170-30-3 |
224-030-0 |
|
1066 |
Hexahydrocyclopenta(c)pyrrole-1-(1H)-ammonium N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide |
|
418-350-1 |
|
1067 |
4,4′-Carbonimidoylbis[N,N-dimethylaniline] and its salts |
492-80-8 |
207-762-5 |
|
1068 |
DNOC (ISO) |
534-52-1 |
208-601-1 |
|
1069 |
Toluidinium chloride |
540-23-8 |
208-740-8 |
|
1070 |
Toluidine sulphate (1:1) |
540-25-0 |
208-741-3 |
|
1071 |
2-(4-tert.-Butylphenyl)ethanol |
5406-86-0 |
410-020-5 |
|
1072 |
Fenthion |
55-38-9 |
200-231-9 |
|
1073 |
Chlordane, pur |
57-74-9 |
200-349-0 |
|
1074 |
Hexan-2-one (Methyl butyl ketone) |
591-78-6 |
209-731-1 |
|
1075 |
Fenarimol |
60168-88-9 |
262-095-7 |
|
1076 |
Acetamide |
60-35-5 |
200-473-5 |
|
1077 |
N-Cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide (Furmecyclox - ISO) |
60568-05-0 |
262-302-0 |
|
1078 |
Dieldrin |
60-57-1 |
200-484-5 |
|
1079 |
4,4′-Isobutylethylidenediphenol |
6807-17-6 |
401-720-1 |
|
1080 |
Chlordimeform |
6164-98-3 |
228-200-5 |
|
1081 |
Amitrole |
61-82-5 |
200-521-5 |
|
1082 |
Carbaryl |
63-25-2 |
200-555-0 |
|
1083 |
Distillates (petroleum), light hydrocracked |
64741-77-1 |
|